BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533-543. [PMID: 11905707 DOI: 10.1016/s1470-2045(01)00486-7] [Cited by in Crossref: 1635] [Cited by in F6Publishing: 510] [Article Influence: 86.1] [Reference Citation Analysis]
Number Citing Articles
1 Xu Y, Li H, Gao RL, Adeyemo O, Itkin M, Kaplan DE. Expansion of interferon-gamma-producing multifunctional CD4+ T-cells and dysfunctional CD8+ T-cells by glypican-3 peptide library in hepatocellular carcinoma patients. Clin Immunol 2011;139:302-13. [PMID: 21419713 DOI: 10.1016/j.clim.2011.02.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
2 Lakatos PL, Hitre E, Szalay F, Zinober K, Fuszek P, Lakatos L, Fischer S, Osztovits J, Gemela O, Veres G. Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients. BMC Cancer. 2007;7:54. [PMID: 17389035 DOI: 10.1186/1471-2407-7-54] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
3 Lother SA, Harding GA, Musto G, Navaratnam S, Pitz MW. Antiestrogen use and survival of women with non-small cell lung cancer in Manitoba, Canada. Horm Cancer 2013;4:270-6. [PMID: 23715671 DOI: 10.1007/s12672-013-0149-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
4 Tougeron D, Di Fiore F, Thureau S, Berbera N, Iwanicki-Caron I, Hamidou H, Paillot B, Michel P. Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. Br J Cancer 2008;99:1586-92. [PMID: 19002180 DOI: 10.1038/sj.bjc.6604749] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 5.5] [Reference Citation Analysis]
5 Mandeville KL, Krabshuis J, Ladep NG, Mulder CJ, Quigley EM, Khan SA. Gastroenterology in developing countries: issues and advances. World J Gastroenterol 2009;15:2839-54. [PMID: 19533805 DOI: 10.3748/wjg.15.2839] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
6 Huang WY, Li CH, Lin CL, Liang JA. Long-term statin use in patients with lung cancer and dyslipidemia reduces the risk of death. Oncotarget 2016;7:42208-15. [PMID: 27283991 DOI: 10.18632/oncotarget.9906] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
7 Adeloye D, David RA, Aderemi AV, Iseolorunkanmi A, Oyedokun A, Iweala EE, Omoregbe N, Ayo CK. An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis. PLoS One 2016;11:e0153496. [PMID: 27073921 DOI: 10.1371/journal.pone.0153496] [Cited by in Crossref: 56] [Cited by in F6Publishing: 31] [Article Influence: 11.2] [Reference Citation Analysis]
8 Matsuda A, Yamaoka K, Tango T. Quality of life in advanced non-small cell lung cancer patients receiving palliative chemotherapy: A meta-analysis of randomized controlled trials. Exp Ther Med 2012;3:134-40. [PMID: 22969858 DOI: 10.3892/etm.2011.368] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
9 Di Maso V, Avellini C, Crocè LS, Rosso N, Quadrifoglio F, Cesaratto L, Codarin E, Bedogni G, Beltrami CA, Tell G, Tiribelli C. Subcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance. Mol Med 2007;13:89-96. [PMID: 17515960 DOI: 10.2119/2006-00084.dimaso] [Cited by in Crossref: 66] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
10 Spiegelberg D, Kuku G, Selvaraju R, Nestor M. Characterization of CD44 variant expression in head and neck squamous cell carcinomas. Tumour Biol 2014;35:2053-62. [PMID: 24122205 DOI: 10.1007/s13277-013-1272-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
11 Hsieh CH, Liu CY, Shueng PW, Chong NS, Chen CJ, Chen MJ, Lin CC, Wang TE, Lin SC, Tai HC, Tien HJ, Chen KH, Wang LY, Hsieh YP, Huang DY, Chen YJ. Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma. Radiat Oncol 2010;5:40. [PMID: 20492727 DOI: 10.1186/1748-717X-5-40] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
12 Minniti G, Lombardi G, Paolini S. Glioblastoma in Elderly Patients: Current Management and Future Perspectives. Cancers (Basel) 2019;11:E336. [PMID: 30857221 DOI: 10.3390/cancers11030336] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 13.5] [Reference Citation Analysis]
13 Chung FY, Huang MY, Yeh CS, Chang HJ, Cheng TL, Yen LC, Wang JY, Lin SR. GLUT1 gene is a potential hypoxic marker in colorectal cancer patients. BMC Cancer 2009;9:241. [PMID: 19619276 DOI: 10.1186/1471-2407-9-241] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
14 Min YW, Gwak GY, Lee MW, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Clinical course of sub-centimeter-sized nodules detected during surveillance for hepatocellular carcinoma. World J Gastroenterol 2012;18:2654-60. [PMID: 22690074 DOI: 10.3748/wjg.v18.i21.2654] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Miura S, Mitsuhashi N, Shimizu H, Kimura F, Yoshidome H, Otsuka M, Kato A, Shida T, Okamura D, Miyazaki M. Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma. BMC Cancer. 2012;12:56. [PMID: 22309595 DOI: 10.1186/1471-2407-12-56] [Cited by in Crossref: 107] [Cited by in F6Publishing: 111] [Article Influence: 11.9] [Reference Citation Analysis]
16 Gao S, Yang Z, Zheng ZY, Yao J, Zhang F, Wu LM, Xie HY, Zhou L, Zheng SS. Reduced expression of DACT2 promotes hepatocellular carcinoma progression: involvement of methylation-mediated gene silencing. World J Surg Oncol 2013;11:57. [PMID: 23496880 DOI: 10.1186/1477-7819-11-57] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
17 Srivastava S, Wong KF, Ong CW, Huak CY, Yeoh KG, Teh M, Luk JM, Salto-Tellez M. A morpho-molecular prognostic model for hepatocellular carcinoma. Br J Cancer. 2012;107:334-339. [PMID: 22713659 DOI: 10.1038/bjc.2012.230] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wang YC, Yang X, Xing LH, Kong WZ. Effects of SAHA on proliferation and apoptosis of hepatocellular carcinoma cells and hepatitis B virus replication. World J Gastroenterol 2013;19:5159-64. [PMID: 23964152 DOI: 10.3748/wjg.v19.i31.5159] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
19 Xu C, Zhang M, Bian L, Li Y, Yao Y, Li D. N-glycosylated SGK196 suppresses the metastasis of basal-like breast cancer cells. Oncogenesis 2020;9:4. [PMID: 31913260 DOI: 10.1038/s41389-019-0188-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
20 Quinn MJ, Cooper N, Rachet B, Mitry E, Coleman MP. Survival from cancer of the breast in women in England and Wales up to 2001. Br J Cancer 2008;99 Suppl 1:S53-5. [PMID: 18813260 DOI: 10.1038/sj.bjc.6604587] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
21 Zhao WC, Yang N, Zhu N, Zhang HB, Fu Y, Zhou HB, Cai WK, Chen BD, Yang GS. Patients with multiple hepatocellular carcinomas within the UCSF criteria have outcomes after curative resection similar to patients within the BCLC early-stage criteria. World J Surg. 2012;36:1811-1823. [PMID: 22526045 DOI: 10.1007/s00268-012-1601-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
22 Schmitz R, Valls AF, Yerbes R, von Richter S, Kahlert C, Loges S, Weitz J, Schneider M, Ruiz de Almodovar C, Ulrich A, Schmidt T. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer. Oncotarget 2016;7:56355-70. [PMID: 27486820 DOI: 10.18632/oncotarget.10889] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
23 Zhao WC, Zhang HB, Yang N, Fu Y, Qian W, Chen BD, Fan LF, Yang GS. Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma. World J Gastroenterol. 2012;18:3272-3281. [PMID: 22783052 DOI: 10.3748/wjg.v18.i25.3272] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
24 Wu LM, Zhang F, Zhou L, Yang Z, Xie HY, Zheng SS. Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation. BMC Cancer 2010;10:399. [PMID: 20678188 DOI: 10.1186/1471-2407-10-399] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
25 Sidharthan S, Kottilil S. Mechanisms of alcohol-induced hepatocellular carcinoma. Hepatol Int 2014;8:452-7. [PMID: 25383134 DOI: 10.1007/s12072-013-9494-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
26 Wang Y, Yu H, Zhang J, Gao J, Ge X, Lou G. Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest. BMC Cancer 2015;15:682. [PMID: 26459308 DOI: 10.1186/s12885-015-1706-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 6.7] [Reference Citation Analysis]
27 Carvalho A, Cunha C, Almeida AJ, Osório NS, Saraiva M, Teixeira-Coelho M, Pedreiro S, Torrado E, Domingues N, Gomes-Alves AG, Marques A, Lacerda JF, da Silva MG, Gomes M, Pinto AC, Torres F, Rendeiro P, Tavares P, Di Ianni M, Medeiros R, Heutink P, Bracci PM, Conde L, Ludovico P, Pedrosa J, Maciel P, Pitzurra L, Aversa F, Marques H, Paiva A, Skibola CF, Romani L, Castro AG, Rodrigues F. The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma. Genes Immun 2012;13:197-201. [PMID: 21866115 DOI: 10.1038/gene.2011.59] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
28 Li X, Zhang YY, Wang Q, Fu SB. Association between endogenous gene expression and growth regulation induced by TGF-beta1 in human gastric cancer cells. World J Gastroenterol 2005;11:61-8. [PMID: 15609398 DOI: 10.3748/wjg.v11.i1.61] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
29 Mongan AM, Kalachand R, King S, O'Farrell NJ, Power D, Ravi N, Muldoon C, O'Byrne K, Reynolds JV. Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgery. Ir J Med Sci. 2015;184:417-423. [PMID: 24879337 DOI: 10.1007/s11845-014-1135-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
30 Abdel Salam I, Gaballa HE, Abdel Wahab N. Serum levels of epidermal growth factor and HER-2 neu in non small-cell lung cancer: prognostic correlation. Med Oncol 2009;26:161-6. [PMID: 19093231 DOI: 10.1007/s12032-008-9102-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
31 Oishi Y, Watanabe Y, Yoshida Y, Sato Y, Hiraishi T, Oikawa R, Maehata T, Suzuki H, Toyota M, Niwa H. Hypermethylation of Sox17 gene is useful as a molecular diagnostic application in early gastric cancer. Tumour Biol. 2012;33:383-393. [PMID: 22161215 DOI: 10.1007/s13277-011-0278-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
32 Flecken T, Spangenberg HC, Thimme R. Immunobiology of hepatocellular carcinoma. Langenbecks Arch Surg. 2012;397:673-680. [PMID: 21479622 DOI: 10.1007/s00423-011-0783-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
33 Bai X, Zhu Y, Jin Y, Guo X, Qian G, Chen T, Zhang J, Wang J, Groopman JD, Gu J. Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma. Carcinogenesis. 2011;32:63-68. [PMID: 20876702 DOI: 10.1093/carcin/bgq195] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
34 Avissar M, Christensen BC, Kelsey KT, Marsit CJ. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 2009;15:2850-5. [PMID: 19351747 DOI: 10.1158/1078-0432.CCR-08-3131] [Cited by in Crossref: 183] [Cited by in F6Publishing: 99] [Article Influence: 15.3] [Reference Citation Analysis]
35 Zhang MF, Zhang ZY, Fu J, Yang YF, Yun JP. Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma. J Transl Med. 2009;7:110. [PMID: 20025780 DOI: 10.1186/1479-5876-7-110] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
36 Yuan H, Cao P, Li HL, Hu HT, Guo CY, Zhao Y, Yao QJ, Geng X. Transarterial chemoembolization with radiofrequency ablation versus hepatectomy in hepatocellular carcinoma beyond the Milan criteria: a retrospective study. Cancer Manag Res 2018;10:5545-52. [PMID: 30519102 DOI: 10.2147/CMAR.S182914] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Fye HK, Wright-Drakesmith C, Kramer HB, Camey S, Nogueira da Costa A, Jeng A, Bah A, Kirk GD, Sharif MI, Ladep NG, Okeke E, Hainaut P, Taylor-Robinson SD, Kessler BM, Mendy ME. Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west African populations. PLoS One 2013;8:e68381. [PMID: 23935864 DOI: 10.1371/journal.pone.0068381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
38 Liu X, Liu X, Sunchen S, Liu M, Shen C, Wu J, Zhao W, Yu B, Liu J. A novel tumor-activated ALA fusion protein for specific inhibition on the growth and invasion of breast cancer cells MDA-MB-231. Drug Deliv 2017;24:1811-7. [PMID: 29172777 DOI: 10.1080/10717544.2017.1406560] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
39 Wu D, Zeng L, Liu F, Zhong Q, Zhang D, Cai C, Zhang W, Wu L, Chen H. Special AT-rich DNA-binding protein-1 expression is associated with liver cancer metastasis. Oncol Lett 2016;12:4377-84. [PMID: 28101200 DOI: 10.3892/ol.2016.5281] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
40 van der Watt PJ, Maske CP, Hendricks DT, Parker MI, Denny L, Govender D, Birrer MJ, Leaner VD. The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation. Int J Cancer 2009;124:1829-40. [PMID: 19117056 DOI: 10.1002/ijc.24146] [Cited by in Crossref: 183] [Cited by in F6Publishing: 154] [Article Influence: 15.3] [Reference Citation Analysis]
41 Dai J, Gu J, Lu C, Lin J, Stewart D, Chang D, Roth JA, Wu X. Genetic variations in the regulator of G-protein signaling genes are associated with survival in late-stage non-small cell lung cancer. PLoS One. 2011;6:e21120. [PMID: 21698121 DOI: 10.1371/journal.pone.0021120] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
42 Massarweh NN, Park JO, Farjah F, Yeung RS, Symons RG, Vaughan TL, Baldwin LM, Flum DR. Trends in the utilization and impact of radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg. 2010;210:441-448. [PMID: 20347736 DOI: 10.1016/j.jamcollsurg.2009.12.026] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
43 Lewis BC, Klimstra DS, Socci ND, Xu S, Koutcher JA, Varmus HE. The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma. Mol Cell Biol. 2005;25:1228-1237. [PMID: 15684377 DOI: 10.1128/mcb.25.4.1228-1237.2005] [Cited by in Crossref: 86] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
44 Haruna Y, Hasegawa N, Imanaka K, Kawamoto S, Inoue A. Clinical Impact of Vitamin K Dosing on Sorafenib Treatment for Hepatocellular Carcinoma. J Cancer. 2017;8:1988-1994. [PMID: 28819398 DOI: 10.7150/jca.18900] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
45 Guan J, Xiao NJ, Chen M, Zhou WL, Zhang YW, Wang S, Dai YM, Li L, Zhang Y, Li QY, Li XZ, Yang M, Wu HB, Chen LH, Liu LY. 18F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer. Medicine (Baltimore) 2016;95:e4421. [PMID: 27472739 DOI: 10.1097/MD.0000000000004421] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
46 Hao JJ, Yao HQ, Dai GY, Kang W, Jia XM, Xu X, Cai Y, Zhan QM, Wang GQ, Wang MR. Chromosomal aneuploidies and combinational fluorescence in situ hybridization probe panels are useful for predicting prognosis for esophageal squamous cell carcinoma. J Gastroenterol 2015;50:155-66. [PMID: 24816430 DOI: 10.1007/s00535-014-0961-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
47 Tang Y, Shu G, Yuan X, Jing N, Song J. FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers. Cell Res. 2011;21:316-326. [PMID: 20820189 DOI: 10.1038/cr.2010.126] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 8.0] [Reference Citation Analysis]
48 Mitry E, Rachet B, Quinn MJ, Cooper N, Coleman MP. Survival from cancer of the colon in England and Wales up to 2001. Br J Cancer 2008;99 Suppl 1:S26-9. [PMID: 18813251 DOI: 10.1038/sj.bjc.6604578] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
49 Nishimura T, Kohara M, Izumi K, Kasama Y, Hirata Y, Huang Y, Shuda M, Mukaidani C, Takano T, Tokunaga Y. Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol Delta24-reductase. J Biol Chem. 2009;284:36442-36452. [PMID: 19861417 DOI: 10.1074/jbc.m109.043232] [Cited by in Crossref: 48] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
50 Skoglund Lundin J, Vandrovcova J, Song B, Zhou X, Zelada-Hedman M, Werelius B, Houlston RS, Lindblom A. TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk. Br J Cancer 2009;100:1674-9. [PMID: 19401691 DOI: 10.1038/sj.bjc.6605054] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
51 Li Y, Dong X, Yin Y, Su Y, Xu Q, Zhang Y, Pang X, Zhang Y, Chen W. BJ-TSA-9, a novel human tumor-specific gene, has potential as a biomarker of lung cancer. Neoplasia 2005;7:1073-80. [PMID: 16354590 DOI: 10.1593/neo.05406] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
52 Zhao J, Zhao Y, Wang H, Gu X, Ji J, Gao C. Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study. Nutr J. 2011;10:49. [PMID: 21569630 DOI: 10.1186/1475-2891-10-49] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
53 Minmin S, Xiaoqian X, Hao C, Baiyong S, Xiaxing D, Junjie X, Xi Z, Jianquan Z, Songyao J. Single nucleotide polymorphisms of Toll-like receptor 4 decrease the risk of development of hepatocellular carcinoma. PLoS One 2011;6:e19466. [PMID: 21559380 DOI: 10.1371/journal.pone.0019466] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
54 Park S, Langley E, Sun JM, Lockton S, Ahn JS, Jain A, Park K, Singh S, Kim P, Ahn MJ. Low EGFR/MET ratio is associated with resistance to EGFR inhibitors in non-small cell lung cancer. Oncotarget 2015;6:30929-38. [PMID: 26439803 DOI: 10.18632/oncotarget.5131] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
55 Wang C, Lu Y, Chen Y, Feng Y, An L, Wang X, Su S, Bai W, Zhou L, Yang Y. Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective study. Clin Exp Metastasis. 2009;26:839-848. [PMID: 19784786 DOI: 10.1007/s10585-009-9283-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
56 Chu YQ, Ye ZY, Tao HQ, Wang YY, Zhao ZS. Relationship between cell adhesion molecules expression and the biological behavior of gastric carcinoma. World J Gastroenterol 2008;14:1990-6. [PMID: 18395897 DOI: 10.3748/wjg.14.1990] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
57 Nozaki I, Hato S, Kobatake T, Ohta K, Kubo Y, Kurita A. Long-term outcome after proximal gastrectomy with jejunal interposition for gastric cancer compared with total gastrectomy. World J Surg. 2013;37:558-564. [PMID: 23254949 DOI: 10.1007/s00268-012-1894-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
58 Bandrés E, Zárate R, Ramirez N, Abajo A, Bitarte N, Garíia-Foncillas J. Pharmacogenomics in colorectal cancer: the first step for individualized-therapy. World J Gastroenterol 2007;13:5888-901. [PMID: 17990354 DOI: 10.3748/wjg.v13.i44.5888] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
59 Yang L, Peng F, Qin J, Zhou H, Wang B. Downregulation of microRNA-196a inhibits human liver cancer cell proliferation and invasion by targeting FOXO1. Oncol Rep 2017;38:2148-54. [PMID: 28791406 DOI: 10.3892/or.2017.5873] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
60 Smith MG, Hold GL, Tahara E, El-Omar EM. Cellular and molecular aspects of gastric cancer. World J Gastroenterol. 2006;12:2979-2990. [PMID: 16718776 DOI: 10.3748/wjg.v12.i19.2979] [Cited by in CrossRef: 144] [Cited by in F6Publishing: 138] [Article Influence: 9.6] [Reference Citation Analysis]
61 Fiala O, Pesek M, Finek J, Minarik M, Benesova L, Bortlicek Z, Topolcan O. Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation. Tumour Biol 2015;36:5801-5. [PMID: 25702091 DOI: 10.1007/s13277-015-3249-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
62 Pourhoseingholi MA. Increased burden of colorectal cancer in Asia. World J Gastrointest Oncol. 2012;4:68-70. [PMID: 22532878 DOI: 10.4251/wjgo.v4.i4.68] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 51] [Article Influence: 9.6] [Reference Citation Analysis]
63 Guan Y, Rao Z, Chen C. miR-30a suppresses lung cancer progression by targeting SIRT1. Oncotarget 2018;9:4924-34. [PMID: 29435152 DOI: 10.18632/oncotarget.23529] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
64 Wang SX, Byrnes A, Verma S, Pancoast JR, Rixe O. Complete remission of unresectable hepatocellular carcinoma treated with reduced dose of sorafenib: a case report. Target Oncol. 2010;5:59-63. [PMID: 20309643 DOI: 10.1007/s11523-010-0133-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
65 Lang K, Akbaba S, Held T, Kargus S, Horn D, Bougatf N, Bernhardt D, Freier K, Rieken S, Debus J, Adeberg S. Definitive radiotherapy vs. postoperative radiotherapy for lower gingival carcinomas of the mandible : A single-center report about outcome and toxicity. Strahlenther Onkol 2019;195:819-29. [PMID: 31267170 DOI: 10.1007/s00066-019-01484-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Sun LC, Tai YY, Liao SM, Lin TY, Shih YL, Chang SF, Huang CW, Chan HM, Huang CJ, Wang JY. Clinical characteristics of second primary cancer in colorectal cancer patients: the impact of colorectal cancer or other second cancer occurring first. World J Surg Oncol 2014;12:73. [PMID: 24678904 DOI: 10.1186/1477-7819-12-73] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
67 Reynolds JK, Levien TL. Quality-of-life assessment in phase III clinical trials of gemcitabine in non-small-cell lung cancer. Drugs Aging 2008;25:893-911. [PMID: 18947258 DOI: 10.2165/0002512-200825110-00001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
68 Gatenby PA, Caygill CP, Ramus JR, Charlett A, Watson A. Barrett’s columnar-lined oesophagus: demographic and lifestyle associations and adenocarcinoma risk. Dig Dis Sci. 2008;53:1175-1185. [PMID: 17939050 DOI: 10.1007/s10620-007-0023-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
69 Mohammed AA, Hamdan AN, Homoud AS. Histopathological Profile of Brain Tumors: A 12-year Retrospective Study from Madinah, Saudi Arabia. Asian J Neurosurg 2019;14:1106-11. [PMID: 31903347 DOI: 10.4103/ajns.AJNS_185_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Ying ZL, Li XJ, Dang H, Wang F, Xu XY. Saikosaponin-d affects the differentiation, maturation and function of monocyte-derived dendritic cells. Exp Ther Med. 2014;7:1354-1358. [PMID: 24940438 DOI: 10.3892/etm] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
71 Jin YJ, Lee JW, Choi YJ, Chung HJ, Kim YS, Lee KY, Ahn SI, Shin WY, Cho SG, Jeon YS. Surgery versus transarterial chemoembolization for solitary large hepatocellular carcinoma of BCLC stage A. J Gastrointest Surg. 2014;18:555-561. [PMID: 24420729 DOI: 10.1007/s11605-013-2440-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
72 Walsh T, Liu JL, Brocklehurst P, Glenny AM, Lingen M, Kerr AR, Ogden G, Warnakulasuriya S, Scully C. Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev 2013;:CD010173. [PMID: 24258195 DOI: 10.1002/14651858.CD010173.pub2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 4.1] [Reference Citation Analysis]
73 Jones HE, Gee JM, Barrow D, Tonge D, Holloway B, Nicholson RI. Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells. Br J Cancer. 2006;95:172-180. [PMID: 16819546 DOI: 10.1038/sj.bjc.6603237] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
74 Luo HC, Zhang HB, Xin XJ, Huang WX. Haplotype-based case-control study of DNA repair gene XRCC3 and hepatocellular carcinoma risk in a Chinese population. Tumour Biol 2014;35:3415-9. [PMID: 24307625 DOI: 10.1007/s13277-013-1451-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
75 Asami K, Kawahara M, Hirashima T, Suzuki H, Okishio K, Omachi N, Tamiya M, Tamiya A, Hirooka A, Nakao K, Tsuji T, Atagi S. Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in Japan. Thorac Cancer 2014;5:289-96. [PMID: 26767015 DOI: 10.1111/1759-7714.12091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
76 Yadlapati S, Efthimiou P. Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk? Biomed Res Int 2016;2016:8631061. [PMID: 27429984 DOI: 10.1155/2016/8631061] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
77 Chen L, Yang X, Yang X, Fan K, Xiao P, Zhang J, Wang X. Association between the expression levels of tumor necrosis factor-α-induced protein 8 and the prognosis of patients with gastric adenocarcinoma. Exp Ther Med 2016;12:238-44. [PMID: 27347043 DOI: 10.3892/etm.2016.3327] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
78 Patwardhan V, Paul S, Corey KE, Mazhar SM, Richter JM, Thiim M, Chung RT. Hepatocellular carcinoma screening rates vary by etiology of cirrhosis and involvement of gastrointestinal sub-specialists. Dig Dis Sci. 2011;56:3316-3322. [PMID: 21805170 DOI: 10.1007/s10620-011-1836-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
79 Fuccio L, Eusebi LH, Bazzoli F. Gastric cancer, Helicobacter pylori infection and other risk factors. World J Gastrointest Oncol. 2010;2:342-347. [PMID: 21160805 DOI: 10.4251/wjgo.v2.i9.342] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
80 Schmid K, Wang X, Haitel A, Sieghart W, Peck-Radosavljevic M, Bodingbauer M, Rasoul-Rockenschaub S, Wrba F. KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study. Virchows Arch 2007;450:143-9. [PMID: 17216189 DOI: 10.1007/s00428-006-0352-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
81 Kobayashi M, Lee H, Nakayama J, Fukuda M. Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection. Glycobiology. 2009;19:453-461. [PMID: 19150806 DOI: 10.1093/glycob/cwp004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
82 Marques-Silva L, Farias LC, Fraga CA, de Oliveira MV, Cardos CM, Fonseca-Silva T, Gomes CC, De-Paula AM, Gomez RS, Guimarães AL. HPV-16/18 detection does not affect the prognosis of head and neck squamous cell carcinoma in younger and older patients. Oncol Lett 2012;3:945-9. [PMID: 22741024 DOI: 10.3892/ol.2012.588] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
83 Ma R, Yang Q, Cao S, Liu S, Cao H, Xu H, Wu J, Feng J. Serum Platelet-Derived Growth Factor Is Significantly Lower in Patients with Lung Cancer and Continued to Decrease After Platinum-Based Chemotherapy. Onco Targets Ther 2020;13:1883-92. [PMID: 32184623 DOI: 10.2147/OTT.S239252] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Shire A, Lomberk G, Lai JP, Zou H, Tsuchiya N, Aderca I, Moser CD, Gulaid KH, Oseini A, Hu C, Warsame O, Jenkins RB, Roberts LR. Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosis. Med Epigenet 2015;3:1-18. [PMID: 26236329 DOI: 10.1159/000375461] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
85 Ren QQ, Fu SJ, Zhao Q, Guo ZY, Ji F, Chen MG, Wu LW, He XS. Prognostic value of preoperative peripheral monocyte count in patients with hepatocellular carcinoma after liver transplantation. Tumour Biol 2016;37:8973-8. [PMID: 26753965 DOI: 10.1007/s13277-015-4758-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
86 Li J, Qiang J, Chen SF, Wang X, Fu J, Chen Y. The impact of L-type amino acid transporter 1 (LAT1) in human hepatocellular carcinoma. Tumour Biol. 2013;34:2977-2981. [PMID: 23696029 DOI: 10.1007/s13277-013-0861-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
87 Zupa A, Improta G, Silvestri A, Pin E, Deng J, Aieta M, Musto P, Nitti D, Mammano E, Liotta L, Belluco C, Wulfkuhle J, Petricoin E 3rd. A pilot characterization of human lung NSCLC by protein pathway activation mapping. J Thorac Oncol 2012;7:1755-66. [PMID: 23154546 DOI: 10.1097/JTO.0b013e3182725fc7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
88 Cools N, Ponsaerts P, Lenjou M, Nijs G, Van Bockstaele DR, Van Tendeloo VF, Berneman ZN. Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic cells. Mol Cancer 2006;5:49. [PMID: 17067378 DOI: 10.1186/1476-4598-5-49] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
89 Ju C, Colgan SP, Eltzschig HK. Hypoxia-inducible factors as molecular targets for liver diseases. J Mol Med (Berl). 2016;94:613-627. [PMID: 27094811 DOI: 10.1007/s00109-016-1408-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 13.0] [Reference Citation Analysis]
90 Chung JC, Naik NK, Lewandowski RJ, Deng J, Mulcahy MF, Kulik LM, Sato KT, Ryu RK, Salem R, Larson AC, Omary RA. Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization. World J Gastroenterol 2010;16:3161-7. [PMID: 20593501 DOI: 10.3748/wjg.v16.i25.3161] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
91 Foda AA, El-Hawary AK, Abdel-Aziz A. Matrix metalloproteinase-13 expression in the progression of colorectal adenoma to carcinoma: Matrix metalloproteinase-13 expression in the colorectal adenoma and carcinoma. Tumour Biol. 2014;35:5653-5658. [PMID: 24563279 DOI: 10.1007/s13277-014-1748-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
92 Wada Y, Takami Y, Matsushima H, Tateishi M, Ryu T, Yoshitomi M, Matsumura T, Saitsu H. The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Study. Intern Med. 2018;57:1345-1353. [PMID: 29279513 DOI: 10.2169/internalmedicine.9826-17] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
93 Johansson D, Andersson C, Moharer J, Johansson A, Behnam-Motlagh P. Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells. Br J Cancer 2010;102:383-91. [PMID: 20010943 DOI: 10.1038/sj.bjc.6605467] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
94 Collins JT, Noble S, Chester J, Davies HE, Evans WD, Lester J, Parry D, Pettit RJ, Byrne A. Association of sarcopenia and observed physical performance with attainment of multidisciplinary team planned treatment in non-small cell lung cancer: an observational study protocol. BMC Cancer 2015;15:544. [PMID: 26204885 DOI: 10.1186/s12885-015-1565-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
95 Huang MD, Chen XF, Xu G, Wu QQ, Zhang JH, Chen GF, Cai Y, Qi FZ. Genetic variation in the NBS1 gene is associated with hepatic cancer risk in a Chinese population. DNA Cell Biol 2012;31:678-82. [PMID: 22070649 DOI: 10.1089/dna.2011.1421] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
96 Wang J, Wu KC, Zhang DX, Fan DM. Antisense angiopoietin-1 inhibits tumorigenesis and angiogenesis of gastric cancer. World J Gastroenterol 2006;12:2450-4. [PMID: 16688843 DOI: 10.3748/wjg.v12.i15.2450] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
97 Zhou Q, Wong CH, Lau CP, Hui CW, Lui VW, Chan SL, Yeo W. Enhanced Antitumor Activity with Combining Effect of mTOR Inhibition and Microtubule Stabilization in Hepatocellular Carcinoma. Int J Hepatol 2013;2013:103830. [PMID: 23509629 DOI: 10.1155/2013/103830] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
98 Yang Z, Zhuang L, Szatmary P, Wen L, Sun H, Lu Y, Xu Q, Chen X. Upregulation of heat shock proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in tumour tissues is associated with poor outcomes from HBV-related early-stage hepatocellular carcinoma. Int J Med Sci. 2015;12:256-263. [PMID: 25798051 DOI: 10.7150/ijms.10735] [Cited by in Crossref: 93] [Cited by in F6Publishing: 77] [Article Influence: 15.5] [Reference Citation Analysis]
99 Siegel AB, Olsen SK, Magun A, Brown RS. Sorafenib: where do we go from here? Hepatology. 2010;52:360-369. [PMID: 20578152 DOI: 10.1002/hep.23633] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 6.1] [Reference Citation Analysis]
100 Yau T, Cheng PN, Chan P, Chan W, Chen L, Yuen J, Pang R, Fan ST, Poon RT. A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma. Invest New Drugs 2013;31:99-107. [PMID: 22426640 DOI: 10.1007/s10637-012-9807-9] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 7.8] [Reference Citation Analysis]
101 Matsubara J, Nishina T, Yamada Y, Moriwaki T, Shimoda T, Kajiwara T, Nakajima TE, Kato K, Hamaguchi T, Shimada Y. Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. Br J Cancer. 2008;98:832-839. [PMID: 18231104 DOI: 10.1038/sj.bjc.6604211] [Cited by in Crossref: 73] [Cited by in F6Publishing: 59] [Article Influence: 5.6] [Reference Citation Analysis]
102 Hosseinzadeh F, Kayvanjoo AH, Ebrahimi M, Goliaei B. Prediction of lung tumor types based on protein attributes by machine learning algorithms. Springerplus 2013;2:238. [PMID: 23888262 DOI: 10.1186/2193-1801-2-238] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
103 Jayaprakash R, Ramesh V, Sridhar MP, Sasikala C. Antioxidant activity of ethanolic extract of Tinospora cordifolia on N-nitrosodiethylamine (diethylnitrosamine) induced liver cancer in male Wister albino rats. J Pharm Bioallied Sci 2015;7:S40-5. [PMID: 26015745 DOI: 10.4103/0975-7406.155791] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
104 Mabula JB, McHembe MD, Koy M, Chalya PL, Massaga F, Rambau PF, Masalu N, Jaka H. Gastric cancer at a university teaching hospital in northwestern Tanzania: a retrospective review of 232 cases. World J Surg Oncol. 2012;10:257. [PMID: 23181624 DOI: 10.1186/1477-7819-10-257] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
105 Bao YX, Cao Q, Yang Y, Mao R, Xiao L, Zhang H, Zhao HR, Wen H. Expression and prognostic significance of golgiglycoprotein73 (GP73) with epithelial-mesenchymal transition (EMT) related molecules in hepatocellular carcinoma (HCC). Diagn Pathol. 2013;8:197. [PMID: 24313979 DOI: 10.1186/1746-1596-8-197] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
106 Lei HY, Chang CP. Lectin of Concanavalin A as an anti-hepatoma therapeutic agent. J Biomed Sci 2009;16:10. [PMID: 19272170 DOI: 10.1186/1423-0127-16-10] [Cited by in Crossref: 67] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
107 Moghimi-Dehkordi B, Safaee A, Zali MR. Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Colorectal Dis. 2008;23:683-688. [PMID: 18330578 DOI: 10.1007/s00384-008-0463-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
108 Madkhali AA, Fadel ZT, Aljiffry MM, Hassanain MM. Surgical treatment for hepatocellular carcinoma. Saudi J Gastroenterol. 2015;21:11-17. [PMID: 25672233 DOI: 10.4103/1319-3767.151216] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
109 Yamaguchi K, Sakai M, Shimokawa T, Yamada Y, Nakamura Y, Furukawa Y. C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer. Br J Cancer 2010;102:325-31. [PMID: 20051959 DOI: 10.1038/sj.bjc.6605500] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
110 Bacchi CE, Ciol H, Queiroga EM, Benine LC, Silva LH, Ojopi EB. Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients. Clinics (Sao Paulo) 2012;67:419-24. [PMID: 22666783 DOI: 10.6061/clinics/2012(05)03] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
111 Li Q, Hu Y, Xi M, He L, Zhao L, Liu M. Sorafenib modulates the radio sensitivity of hepatocellular carcinoma cells in vitro in a schedule-dependent manner. BMC Cancer 2012;12:485. [PMID: 23088517 DOI: 10.1186/1471-2407-12-485] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
112 Yuan L, Dong L, Yu G, Fan W, Zhang L, Wang P, Hu X, Zhao M. Aberrant expression of B7‑H4 may contribute to the development of hepatocellular carcinoma. Mol Med Rep 2016;14:5015-24. [PMID: 27840912 DOI: 10.3892/mmr.2016.5887] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
113 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)] [Reference Citation Analysis]
114 Quang YN, Vu J, Yuk J, Li CS, Chen M, Bowlus CL. Prevalence of hepatitis B surface antigen in US-born and foreign-born Asian/Pacific Islander college students. J Am Coll Health 2010;59:37-41. [PMID: 20670927 DOI: 10.1080/07448481.2010.486811] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
115 Li X, Lin W, Wang H, Lin W, Lin S, Lin Y. Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma. Med Oncol 2013;30:746. [PMID: 24122256 DOI: 10.1007/s12032-013-0746-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
116 Nam SY. Obesity-Related Digestive Diseases and Their Pathophysiology. Gut Liver 2017;11:323-34. [PMID: 27890867 DOI: 10.5009/gnl15557] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 10.3] [Reference Citation Analysis]
117 Di Maso V, Avellini C, Crocè LS, Rosso N, Quadrifoglio F, Cesaratto L, Codarin E, Bedogni G, Beltrami CA, Tell G. Subcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance. Mol Med. 2007;13:89-96. [PMID: 17515960 DOI: 10.2119/2006-00084.di] [Reference Citation Analysis]
118 Schroeder RD, Choi W, Hong DS, McConkey DJ. Autophagy is required for crizotinib-induced apoptosis in MET-amplified gastric cancer cells. Oncotarget 2017;8:51675-87. [PMID: 28881678 DOI: 10.18632/oncotarget.18386] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
119 D'Anzeo M, Faloppi L, Scartozzi M, Giampieri R, Bianconi M, Del Prete M, Silvestris N, Cascinu S. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment. Molecules. 2014;19:6393-6406. [PMID: 24853455 DOI: 10.3390/molecules19056393] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
120 Bourgo RJ, Braden WA, Wells SI, Knudsen ES. Activation of the retinoblastoma tumor suppressor mediates cell cycle inhibition and cell death in specific cervical cancer cell lines. Mol Carcinog 2009;48:45-55. [PMID: 18506774 DOI: 10.1002/mc.20456] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
121 Sun L, Quan H, Xie C, Wang L, Hu Y, Lou L. Phosphodiesterase 3/4 inhibitor zardaverine exhibits potent and selective antitumor activity against hepatocellular carcinoma both in vitro and in vivo independently of phosphodiesterase inhibition. PLoS One 2014;9:e90627. [PMID: 24598942 DOI: 10.1371/journal.pone.0090627] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
122 Song GM, Tian X, Liu XL, Chen H, Zhou JG, Bian W, Chen WQ. Concurrent chemo-radiotherapy with S-1 as an alternative therapy for elderly Chinese patients with non-metastatic esophageal squamous cancer: evidence based on a systematic review and meta-analysis. Oncotarget 2017;8:37963-73. [PMID: 28415814 DOI: 10.18632/oncotarget.16302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Li Z, Gao X, Peng X, May Chen MJ, Li Z, Wei B, Wen X, Wei B, Dong Y, Bu Z, Wu A, Wu Q, Tang L, Li Z, Liu Y, Zhang L, Jia S, Zhang L, Shan F, Zhang J, Wu X, Ji X, Ji K, Wu X, Shi J, Xing X, Wu J, Lv G, Shen L, Ji X, Liang H, Ji J. Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy. Sci Adv 2020;6:eaay4211. [PMID: 32133402 DOI: 10.1126/sciadv.aay4211] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
124 Kobayashi M, Lee H, Nakayama J, Fukuda M. Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection. Curr Drug Metab. 2009;10:29-40. [PMID: 19149511 DOI: 10.2174/138920009787048428] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
125 Jiang WP, Wang Z, Xu LX, Peng X, Chen F. Diagnostic model of saliva peptide finger print analysis of oral squamous cell carcinoma patients using weak cation exchange magnetic beads. Biosci Rep 2015;35:e00211. [PMID: 26182373 DOI: 10.1042/BSR20150023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
126 Jia JB, Zhuang PY, Sun HC, Zhang JB, Zhang W, Zhu XD, Xiong YQ, Xu HX, Tang ZY. Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival. J Cancer Res Clin Oncol. 2009;135:847-854. [PMID: 19066962 DOI: 10.1007/s00432-008-0521-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
127 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)60617-6] [Cited by in Crossref: 635] [Cited by in F6Publishing: 366] [Article Influence: 52.9] [Reference Citation Analysis]
128 Sun CK, Chua MS, He J, So SK. Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2. Neoplasia. 2011;13:735-747. [PMID: 21847365 DOI: 10.1593/neo.11664] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
129 Kitisin K, Packiam V, Steel J, Humar A, Gamblin TC, Geller DA, Marsh JW, Tsung A. Presentation and outcomes of hepatocellular carcinoma patients at a western centre. HPB (Oxford) 2011;13:712-22. [PMID: 21929672 DOI: 10.1111/j.1477-2574.2011.00362.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
130 Cornes P. The economic pressures for biosimilar drug use in cancer medicine. Target Oncol 2012;7 Suppl 1:S57-67. [PMID: 22249658 DOI: 10.1007/s11523-011-0196-3] [Cited by in Crossref: 63] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
131 Li JQ, Chen J, Liu NN, Yang L, Zeng Y, Wang B, Wang XR. Ku80 gene G-1401T promoter polymorphism and risk of gastric cancer. World J Gastroenterol. 2011;17:2131-2136. [PMID: 21547134 DOI: 10.3748/wjg.v17.i16.2131] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
132 Leuthardt EC, Duan C, Kim MJ, Campian JL, Kim AH, Miller-Thomas MM, Shimony JS, Tran DD. Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier. PLoS One 2016;11:e0148613. [PMID: 26910903 DOI: 10.1371/journal.pone.0148613] [Cited by in Crossref: 91] [Cited by in F6Publishing: 63] [Article Influence: 18.2] [Reference Citation Analysis]
133 Ji J, Wang H, Li Y, Zheng L, Yin Y, Zou Z, Zhou F, Zhou W, Shen F, Gao C. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study. PLoS One 2016;11:e0153227. [PMID: 27070780 DOI: 10.1371/journal.pone.0153227] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
134 Liu Z, Zhang J, Gao Y, Pei L, Zhou J, Gu L, Zhang L, Zhu B, Hattori N, Ji J, Yuasa Y, Kim W, Ushijima T, Shi H, Deng D. Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasis. Clin Cancer Res. 2014;20:4598-4612. [PMID: 25009298 DOI: 10.1158/1078-0432.ccr-13-3380] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 7.6] [Reference Citation Analysis]
135 Sayir F, Cobanoğlu U, Sehitoğulları A. The use of LigaSure Vessel Sealing System in Ivor Lewis esophagectomy. J Cardiothorac Surg 2012;7:10. [PMID: 22273539 DOI: 10.1186/1749-8090-7-10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
136 Yaoxian W, Hui Y, Yunyan Z, Yanqin L, Xin G, Xiaoke W. Emodin induces apoptosis of human cervical cancer hela cells via intrinsic mitochondrial and extrinsic death receptor pathway. Cancer Cell Int 2013;13:71. [PMID: 23866157 DOI: 10.1186/1475-2867-13-71] [Cited by in Crossref: 58] [Cited by in F6Publishing: 39] [Article Influence: 7.3] [Reference Citation Analysis]
137 Yoon SY, Thong MK, Taib NA, Yip CH, Teo SH. Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study. Fam Cancer 2011;10:199-205. [PMID: 21318382 DOI: 10.1007/s10689-011-9420-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
138 Liu J, Su M, Wang J, Zhang G, Zhou J, Zhang A, Ren Z, Zheng X, Hong S, Wang S, Zhang R. A novel grade-lymph node ratio model predicts the prognosis of the advanced gastric cancer patients after neoadjuvant radiotherapy. Oncotarget 2017;8:14058-67. [PMID: 27740935 DOI: 10.18632/oncotarget.12573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
139 Saito Y, Suzuki H, Hibi T. The role of microRNAs in gastrointestinal cancers. J Gastroenterol. 2009;44 Suppl 19:18-22. [PMID: 19148788 DOI: 10.1007/s00535-008-2285-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
140 Mitry E, Rachet B, Quinn MJ, Cooper N, Coleman MP. Survival from cancer of the oesophagus in England and Wales up to 2001. Br J Cancer 2008;99 Suppl 1:S11-3. [PMID: 18813240 DOI: 10.1038/sj.bjc.6604572] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
141 Kim YK, Koo NY, Yun PY. Anticancer effects of CKD-602 (Camtobell®) via G2/M phase arrest in oral squamous cell carcinoma cell lines. Oncol Lett 2015;9:136-42. [PMID: 25435947 DOI: 10.3892/ol.2014.2648] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
142 Duijm LE, Groenewoud JH, Jansen FH, Fracheboud J, van Beek M, de Koning HJ. Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening. Br J Cancer 2004;91:1795-9. [PMID: 15505630 DOI: 10.1038/sj.bjc.6602158] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
143 Amadou A, Hainaut P, Romieu I. Role of obesity in the risk of breast cancer: lessons from anthropometry. J Oncol 2013;2013:906495. [PMID: 23431300 DOI: 10.1155/2013/906495] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 6.5] [Reference Citation Analysis]
144 Mo ML, Okamoto J, Chen Z, Hirata T, Mikami I, Bosco-Clément G, Li H, Zhou HM, Jablons DM, He B. Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma. PLoS One 2013;8:e71816. [PMID: 23977152 DOI: 10.1371/journal.pone.0071816] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
145 Tan GH, Huang FY, Wang H, Huang YH, Lin YY, Li YN. Immunotherapy of hepatoma with a monoclonal antibody against murine endoglin. World J Gastroenterol 2007;13:2479-83. [PMID: 17552032 DOI: 10.3748/wjg.v13.i17.2479] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
146 Hu H, Luo SJ, Cao ZR, Wu Y, Mo Z, Wang Y, Yu L, Chen Y, Xu L, Zhang SJ. Depressive Disorder promotes Hepatocellular Carcinoma metastasis via upregulation of ABCG2 gene expression and maintenance of self-renewal. J Cancer 2020;11:5309-17. [PMID: 32742477 DOI: 10.7150/jca.45712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
147 Chandanos E, Lindblad M, Jia C, Rubio CA, Ye W, Lagergren J. Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden. Br J Cancer. 2006;95:118-122. [PMID: 16755290 DOI: 10.1038/sj.bjc.6603214] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
148 Magnussen A, Parsi MA. Aflatoxins, hepatocellular carcinoma and public health. World J Gastroenterol 2013;19:1508-12. [PMID: 23539499 DOI: 10.3748/wjg.v19.i10.1508] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 39] [Article Influence: 8.4] [Reference Citation Analysis]
149 Kleespies A, Füessl KE, Seeliger H, Eichhorn ME, Müller MH, Rentsch M, Thasler WE, Angele MK, Kreis ME, Jauch KW. Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer. Int J Colorectal Dis. 2009;24:1097-1109. [PMID: 19495779 DOI: 10.1007/s00384-009-0734-y] [Cited by in Crossref: 78] [Cited by in F6Publishing: 56] [Article Influence: 6.5] [Reference Citation Analysis]
150 Li Q, Kakizaki M, Kuriyama S, Sone T, Yan H, Nakaya N, Mastuda-Ohmori K, Tsuji I. Green tea consumption and lung cancer risk: the Ohsaki study. Br J Cancer 2008;99:1179-84. [PMID: 18766189 DOI: 10.1038/sj.bjc.6604645] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
151 Ghoshal U, Tripathi S, Kumar S, Mittal B, Chourasia D, Kumari N, Krishnani N, Ghoshal UC. Genetic polymorphism of cytochrome P450 (CYP) 1A1, CYP1A2, and CYP2E1 genes modulate susceptibility to gastric cancer in patients with Helicobacter pylori infection. Gastric Cancer. 2014;17:226-234. [PMID: 23686565 DOI: 10.1007/s10120-013-0269-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
152 García Rodríguez LA, Lagergren J, Lindblad M. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut 2006;55:1538-44. [PMID: 16785284 DOI: 10.1136/gut.2005.086579] [Cited by in Crossref: 123] [Cited by in F6Publishing: 100] [Article Influence: 8.2] [Reference Citation Analysis]
153 Jiang X, Xiang G, Wang Y, Zhang L, Yang X, Cao L, Peng H, Xue P, Chen D. MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-β RII. Mol Cells. 2012;33:545-551. [PMID: 22684895 DOI: 10.1007/s10059-012-2267-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
154 Salazar CR, Francois F, Li Y, Corby P, Hays R, Leung C, Bedi S, Segers S, Queiroz E, Sun J, Wang B, Ho H, Craig R, Cruz GD, Blaser MJ, Perez-Perez G, Hayes RB, Dasanayake A, Pei Z, Chen Y. Association between oral health and gastric precancerous lesions. Carcinogenesis 2012;33:399-403. [PMID: 22139442 DOI: 10.1093/carcin/bgr284] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
155 Xie HL, Su Q, He XS, Liang XQ, Zhou JG, Song Y, Li YQ. Expression of p21(WAF1) and p53 and polymorphism of p21(WAF1) gene in gastric carcinoma. World J Gastroenterol 2004;10:1125-31. [PMID: 15069711 DOI: 10.3748/wjg.v10.i8.1125] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
156 Macey R, Walsh T, Brocklehurst P, Kerr AR, Liu JL, Lingen MW, Ogden GR, Warnakulasuriya S, Scully C. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev 2015;:CD010276. [PMID: 26021841 DOI: 10.1002/14651858.CD010276.pub2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
157 Li X, Yue ZC, Zhang YY, Bai J, Meng XN, Geng JS, Fu SB. Elevated serum level and gene polymorphisms of TGF-beta1 in gastric cancer. J Clin Lab Anal. 2008;22:164-171. [PMID: 18484655 DOI: 10.1002/jcla.20236] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
158 Kwon HC, Oh SY, Lee S, Kim SH, Kim HJ. Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: a pilot study. World J Gastroenterol 2007;13:6231-5. [PMID: 18069765 DOI: 10.3748/wjg.v13.i46.6231] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
159 Khor TO, Gul YA, Ithnin H, Seow HF. A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma. Int J Colorectal Dis. 2006;21:291-300. [PMID: 16041507 DOI: 10.1007/s00384-005-0002-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
160 Gali-Muhtasib H, Ocker M, Kuester D, Krueger S, El-Hajj Z, Diestel A, Evert M, El-Najjar N, Peters B, Jurjus A, Roessner A, Schneider-Stock R. Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models. J Cell Mol Med. 2008;12:330-342. [PMID: 18366456 DOI: 10.1111/j.1582-4934.2007.00095.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 75] [Article Influence: 6.8] [Reference Citation Analysis]
161 Ko CJ, Chien SY, Chou CT, Chen LS, Chen ML, Chen YL. Factors affecting prognosis of small hepatocellular carcinoma in Taiwanese patients following hepatic resection. Can J Gastroenterol 2011;25:485-91. [PMID: 21912759 DOI: 10.1155/2011/790528] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
162 Lee JY, Na II, Jang SH, Hwang YI, Choe du H, Kim CH, Baek H. Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers. J Thorac Dis 2013;5:758-63. [PMID: 24409352 DOI: 10.3978/j.issn.2072-1439.2013.11.24] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
163 Belharazem D, Kirchner M, Geissler F, Bugert P, Spahn M, Kneitz B, Riedmiller H, Sauer C, Küffer S, Trojan L, Bolenz C, Michel MS, Marx A, Ströbel P. Relaxed imprinting of IGF2 in peripheral blood cells of patients with a history of prostate cancer. Endocr Connect 2012;1:87-94. [PMID: 23781309 DOI: 10.1530/EC-12-0054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
164 Xu YC, Xu Q, Li JJ, Gu XF, Lin XL, Sun L, Lu HM, Tang L, Ma Y, Lu Z, Wang HX. Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial. J Cancer Res Clin Oncol 2016;142:1315-23. [PMID: 26941189 DOI: 10.1007/s00432-016-2127-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
165 Zhan Y, Zheng N, Teng F, Bao L, Liu F, Zhang M, Guo M, Guo W, Ding G, Wang Q. MiR-199a/b-5p inhibits hepatocellular carcinoma progression by post-transcriptionally suppressing ROCK1. Oncotarget. 2017;8:67169-67180. [PMID: 28978024 DOI: 10.18632/oncotarget.18052] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
166 Goekkurt E, Hoehn S, Wolschke C, Wittmer C, Stueber C, Hossfeld DK, Stoehlmacher J. Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients. Br J Cancer 2006;94:281-6. [PMID: 16317430 DOI: 10.1038/sj.bjc.6602891] [Cited by in Crossref: 100] [Cited by in F6Publishing: 80] [Article Influence: 6.7] [Reference Citation Analysis]
167 Shen WF, Zhong W, Xu F, Kan T, Geng L, Xie F, Sui CJ, Yang JM. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol. 2009;15:5976-5982. [PMID: 20014463 DOI: 10.3748/wjg.15.5976] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 59] [Article Influence: 6.6] [Reference Citation Analysis]
168 Kwon OS, Jung YK, Kim YS, Kim SG, Kim YS, Lee JI, Lee JW, Kim YS, Chun BC, Kim JH. Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study. Korean J Hepatol. 2010;16:308-314. [PMID: 20924214 DOI: 10.3350/kjhep.2010.16.3.308] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
169 Suh DH, Kim JW, Aziz MF, Devi UK, Ngan HY, Nam JH, Kim SC, Kato T, Ryu HS, Fujii S, Lee YS, Kim JH, Kim TJ, Kim YT, Wang KL, Lee TS, Ushijima K, Shin SG, Chia YN, Wilailak S, Park SY, Katabuchi H, Kamura T, Kang SB. Asian society of gynecologic oncology workshop 2010. J Gynecol Oncol 2010;21:137-50. [PMID: 20922136 DOI: 10.3802/jgo.2010.21.3.137] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
170 Moon SM, Kim SA, Yoon JH, Ahn SG. HOXC6 is deregulated in human head and neck squamous cell carcinoma and modulates Bcl-2 expression. J Biol Chem 2012;287:35678-88. [PMID: 22896703 DOI: 10.1074/jbc.M112.361675] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
171 Okada F, Kobayashi M, Tanaka H, Kobayashi T, Tazawa H, Iuchi Y, Onuma K, Hosokawa M, Dinauer MC, Hunt NH. The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells. Am J Pathol 2006;169:294-302. [PMID: 16816381 DOI: 10.2353/ajpath.2006.060073] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
172 Tian C, Zhou ZG, Meng WJ, Sun XF, Yu YY, Li L, Luo HZ, Yang L, Zhou B, Gu J. Overexpression of connective tissue growth factor WISP-1 in Chinese primary rectal cancer patients. World J Gastroenterol 2007;13:3878-82. [PMID: 17657846 DOI: 10.3748/wjg.v13.i28.3878] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
173 Shimada R, Iinuma H, Akahane T, Horiuchi A, Watanabe T. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients. Oncol Rep 2012;27:947-53. [PMID: 22267181 DOI: 10.3892/or.2012.1649] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
174 Newton AD, Datta J, Loaiza-Bonilla A, Karakousis GC, Roses RE. Neoadjuvant therapy for gastric cancer: current evidence and future directions. J Gastrointest Oncol. 2015;6:534-543. [PMID: 26487948 DOI: 10.3978/j.issn.2078-6891.2015.047] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
175 Milrot E, Jackman A, Flescher E, Gonen P, Kelson I, Keisari Y, Sherman L. Enhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin, X or alpha radiation. Invest New Drugs. 2013;31:333-344. [PMID: 22956285 DOI: 10.1007/s10637-012-9870-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
176 Gao Q, Yuan Y, Gan HZ, Peng Q. Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis. Oncol Lett. 2015;9:2381-2387. [PMID: 26137075 DOI: 10.3892/ol.2015.2988] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
177 Jin Q, Menter DG, Mao L, Hong WK, Lee HY. Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure. Carcinogenesis 2008;29:1614-22. [PMID: 18635526 DOI: 10.1093/carcin/bgm234] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
178 Li J, Huang Z, Wei L. Bioinformatics analysis of the gene expression profile of hepatocellular carcinoma: preliminary results. Contemp Oncol (Pozn) 2016;20:20-7. [PMID: 27095935 DOI: 10.5114/wo.2016.58497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
179 Bidkhori G, Moeini A, Masoudi-Nejad A. Modeling of tumor progression in NSCLC and intrinsic resistance to TKI in loss of PTEN expression. PLoS One 2012;7:e48004. [PMID: 23133538 DOI: 10.1371/journal.pone.0048004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
180 Nam SO, Yotsumoto F, Miyata K, Fukagawa S, Yamada H, Kuroki M, Miyamoto S. Warburg effect regulated by amphiregulin in the development of colorectal cancer. Cancer Med. 2015;4:575-587. [PMID: 25644309 DOI: 10.1002/cam4.416] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
181 Huang Y, Li X, He J, Chen L, Huang H, Liang M, Zhu Q, Huang Y, Wang L, Pan C. Genetic polymorphisms in XRCC1 genes and colorectal cancer susceptibility. World J Surg Oncol. 2015;13:244. [PMID: 26271249 DOI: 10.1186/s12957-015-0650-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
182 Xiao M, Dai X, He X, Zhou R, Zhang B, Hu G, Huang Z, Fan X. Paris saponin I induces G₂/M cell cycle arrest and apoptosis in human gastric carcinoma SGC7901 cells. J Huazhong Univ Sci Technolog Med Sci 2011;31:768-72. [PMID: 22173496 DOI: 10.1007/s11596-011-0674-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
183 Okamoto I. Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan. Int J Clin Oncol 2008;13:112-6. [PMID: 18463953 DOI: 10.1007/s10147-007-0754-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
184 Oeda S, Iwane S, Takasaki M, Furukawa NE, Otsuka T, Eguchi Y, Anzai K. Optimal Follow-up of Patients with Viral Hepatitis Improves the Detection of Early-stage Hepatocellular Carcinoma and the Prognosis of Survival. Intern Med. 2016;55:2749-2758. [PMID: 27725532 DOI: 10.2169/internalmedicine.55.6730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
185 Ueda K, Saichi N, Takami S, Kang D, Toyama A, Daigo Y, Ishikawa N, Kohno N, Tamura K, Shuin T, Nakayama M, Sato TA, Nakamura Y, Nakagawa H. A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinoma. PLoS One 2011;6:e18567. [PMID: 21533267 DOI: 10.1371/journal.pone.0018567] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
186 Ronckers CM, Erdmann CA, Land CE. Radiation and breast cancer: a review of current evidence. Breast Cancer Res. 2005;7:21-32. [PMID: 15642178 DOI: 10.1186/bcr970] [Cited by in Crossref: 200] [Cited by in F6Publishing: 129] [Article Influence: 11.8] [Reference Citation Analysis]
187 Wang Y, Ma J, Chow SC, Li CH, Xiao Z, Feng R, Fu J, Chen Y. A potential antitumor ellagitannin, davidiin, inhibited hepatocellular tumor growth by targeting EZH2. Tumour Biol. 2014;35:205-212. [PMID: 23897557 DOI: 10.1007/s13277-013-1025-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
188 de Guadalupe Chávez-López M, Pérez-Carreón JI, Zuñiga-García V, Díaz-Chávez J, Herrera LA, Caro-Sánchez CH, Acuña-Macías I, Gariglio P, Hernández-Gallegos E, Chiliquinga AJ, Camacho J. Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC. Tumour Biol 2015;36:6149-58. [PMID: 25783527 DOI: 10.1007/s13277-015-3299-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
189 You Z, Chen LP, Ye H. Predictors of microvascular invasion in patients with solitary small hepatitis B related hepatocellular carcinoma. Pak J Med Sci 2014;30:331-4. [PMID: 24772137 DOI: 10.12669/pjms.302.4652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
190 Wu GY, Hasenberg T, Magdeburg R, Bönninghoff R, Sturm JW, Keese M. Association between EGF, TGF-beta1, VEGF gene polymorphism and colorectal cancer. World J Surg 2009;33:124-9. [PMID: 19011936 DOI: 10.1007/s00268-008-9784-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
191 Cao XL, Li H, Yu XL, Liang P, Dong BW, Fan J, Li M, Liu FY. Predicting early intrahepatic recurrence of hepatocellular carcinoma after microwave ablation using SELDI-TOF proteomic signature. PLoS One 2013;8:e82448. [PMID: 24349287 DOI: 10.1371/journal.pone.0082448] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
192 Qi J, Wang J, Katayama H, Sen S, Liu SM. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. neo 2012;60:135-42. [DOI: 10.4149/neo_2013_018] [Cited by in Crossref: 75] [Cited by in F6Publishing: 80] [Article Influence: 8.3] [Reference Citation Analysis]
193 Yokoyama S, Takeuchi K, Shibata Y, Kageyama S, Matsumi R, Takeshita T, Yamashita Y. Characterization of oral microbiota and acetaldehyde production. J Oral Microbiol 2018;10:1492316. [PMID: 30013723 DOI: 10.1080/20002297.2018.1492316] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
194 Yu Q, Xu L, Chen L, Sun B, Yang Z, Lu K, Yang Z. Vinculin expression in non-small cell lung cancer. J Int Med Res 2020;48:300060519839523. [PMID: 30947597 DOI: 10.1177/0300060519839523] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
195 Zhao WD, Guan S, Zhou KR, Li H, Peng WJ, Tang F, Chen ZW. In vivo detection of metabolic changes by 1H-MRS in the DEN-induced hepatocellular carcinoma in Wistar rat. J Cancer Res Clin Oncol. 2005;131:597-602. [PMID: 15991046 DOI: 10.1007/s00432-005-0684-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
196 Sherman SM, Lane EL. Awareness of Risk Factors for Breast, Lung and Cervical Cancer in a UK Student Population. J Cancer Educ 2015;30:660-3. [PMID: 25510367 DOI: 10.1007/s13187-014-0770-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
197 Lindeberg S. Dietary shifts and human health: cancer and cardiovascular disease in a sustainable world. J Gastrointest Cancer 2012;43:8-12. [PMID: 22081408 DOI: 10.1007/s12029-011-9345-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
198 Zeng GQ, Yi H, Zhang PF, Li XH, Hu R, Li MY, Li C, Qu JQ, Deng X, Xiao ZQ. The function and significance of SELENBP1 downregulation in human bronchial epithelial carcinogenic process. PLoS One 2013;8:e71865. [PMID: 23977169 DOI: 10.1371/journal.pone.0071865] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
199 Jian G, Songwen Z, Ling Z, Qinfang D, Jie Z, Liang T, Caicun Z. Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer. J Cancer Res Clin Oncol 2010;136:1341-7. [PMID: 20155428 DOI: 10.1007/s00432-010-0785-z] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
200 Krüger M, Hansen T, Kasaj A, Moergel M. The Correlation between Chronic Periodontitis and Oral Cancer. Case Rep Dent 2013;2013:262410. [PMID: 23936684 DOI: 10.1155/2013/262410] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
201 Qiu GB, Gong LG, Hao DM, Zhen ZH, Sun KL. Expression of MTLC gene in gastric carcinoma. World J Gastroenterol 2003;9:2160-3. [PMID: 14562369 DOI: 10.3748/wjg.v9.i10.2160] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
202 Nakao M, Muramatsu H, Sone K, Aoki S, Akiko H, Kagawa Y, Sato H, Kunieda T. Epidermal growth factor receptor-tyrosine kinase inhibitors for non-small-cell lung cancer patients aged 80 years or older: A retrospective analysis. Mol Clin Oncol 2015;3:403-7. [PMID: 25798276 DOI: 10.3892/mco.2014.453] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
203 Ibrahim ZS. Chenodeoxycholic acid increases the induction of CYP1A1 in HepG2 and H4IIE cells. Exp Ther Med 2015;10:1976-82. [PMID: 26640583 DOI: 10.3892/etm.2015.2719] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
204 Ding X, Yang LY, Huang GW, Wang W, Lu WQ. ADAM17 mRNA expression and pathological features of hepatocellular carcinoma. World J Gastroenterol 2004;10:2735-9. [PMID: 15309730 DOI: 10.3748/wjg.v10.i18.2735] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 52] [Article Influence: 3.3] [Reference Citation Analysis]
205 Yang YF, Chang YC, Jan YH, Yang CJ, Huang MS, Hsiao M. Squalene synthase promotes the invasion of lung cancer cells via the osteopontin/ERK pathway. Oncogenesis 2020;9:78. [PMID: 32862200 DOI: 10.1038/s41389-020-00262-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
206 Zhuang PY, Shen J, Zhu XD, Lu L, Wang L, Tang ZY, Sun HC. Prognostic roles of cross-talk between peritumoral hepatocytes and stromal cells in hepatocellular carcinoma involving peritumoral VEGF-C, VEGFR-1 and VEGFR-3. PLoS One. 2013;8:e64598. [PMID: 23737988 DOI: 10.1371/journal.pone.0064598] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
207 Lee JH, Lee SW. The Roles of Carcinoembryonic Antigen in Liver Metastasis and Therapeutic Approaches. Gastroenterol Res Pract 2017;2017:7521987. [PMID: 28588612 DOI: 10.1155/2017/7521987] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
208 Liu H, Xu HW, Zhang YZ, Huang Y, Han GQ, Liang TJ, Wei LL, Qin CY, Qin CK. Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice. World J Gastroenterol 2015;21:10367-74. [PMID: 26420963 DOI: 10.3748/wjg.v21.i36.10367] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
209 Hall AJ, Wild CP. Liver cancer in low and middle income countries. BMJ 2003;326:994-5. [PMID: 12742895 DOI: 10.1136/bmj.326.7397.994] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
210 Tampellini M, Saini A, Alabiso I, Bitossi R, Brizzi MP, Sculli CM, Berruti A, Gorzegno G, Magnino A, Sperti E, Miraglia S, Forti L, Alabiso O, Aglietta M, Harris A, Dogliotti L. The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients. Br J Cancer 2006;95:13-20. [PMID: 16773070 DOI: 10.1038/sj.bjc.6603204] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
211 Ding X, Yang LY, Huang GW, Yang JQ, Liu HL, Wang W, Peng JX, Yang JQ, Tao YM, Chang ZG, Ling XS. Role of AFP mRNA expression in peripheral blood as a predictor for postsurgical recurrence of hepatocellular carcinoma: a systematic review and meta-analysis. World J Gastroenterol 2005;11:2656-61. [PMID: 15849829 DOI: 10.3748/wjg.v11.i17.2656] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
212 Yuh YJ, Lee HR, Kim SR. Gemcitabine and carboplatin combination chemotherapy for elderly patients with advanced Non-Small Cell Lung Cancer: a feasibility study. Cancer Res Treat 2008;40:116-20. [PMID: 19688117 DOI: 10.4143/crt.2008.40.3.116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
213 Yang Y, Lu Y, Wang C, Bai W, Qu J, Chen Y, Chang X, An L, Zhou L, Zeng Z, Lou M, Lv J. Cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma. Exp Ther Med. 2012;3:171-180. [PMID: 22969864 DOI: 10.3892/etm.2011.398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
214 Yang S, Lin Q, Lin W, Hu W, Wang G. Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review. World J Surg Oncol 2016;14:159. [PMID: 27282382 DOI: 10.1186/s12957-016-0912-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
215 Jin YJ, Chung YH, Kim JA, Park WH, Lee D, Seo DD, Ryu SH, Jang MK, Yu E, Lee YJ. Factors predisposing metastatic tumor antigen 1 overexpression in hepatitis B virus associated hepatocellular carcinoma. Dig Dis Sci. 2012;57:2917-2923. [PMID: 22777614 DOI: 10.1007/s10620-012-2296-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
216 Kinghorn AD, Carcache de Blanco EJ, Chai HB, Orjala J, Farnsworth NR, Soejarto DD, Oberlies NH, Wani MC, Kroll DJ, Pearce CJ, Swanson SM, Kramer RA, Rose WC, Fairchild CR, Vite GD, Emanuel S, Jarjoura D, Cope FO. Discovery of anticancer agents of diverse natural origin. Pure Appl Chem 2009;81:1051-63. [PMID: 20046887 DOI: 10.1351/PAC-CON-08-10-16] [Cited by in Crossref: 63] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
217 Senkus-Konefka E, Dziadziuszko R, Bednaruk-Młyński E, Pliszka A, Kubrak J, Lewandowska A, Małachowski K, Wierzchowski M, Matecka-Nowak M, Jassem J. A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC). Br J Cancer 2005;92:1038-45. [PMID: 15770205 DOI: 10.1038/sj.bjc.6602477] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
218 Chattopadhyay K. A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer. Indian J Hum Genet 2011;17:132-44. [PMID: 22345983 DOI: 10.4103/0971-6866.92087] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
219 Yuvaraja TB, Waigankar S, Bakshi G, Prakash G. Genitourinary cancers: Summary of Indian data. South Asian J Cancer 2016;5:122-4. [PMID: 27606296 DOI: 10.4103/2278-330X.187577] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
220 Lee SH, Jin YJ, Lee JW. Survival benefit of radiofrequency ablation for solitary (3-5 cm) hepatocellular carcinoma: An analysis for nationwide cancer registry. Medicine (Baltimore) 2017;96:e8486. [PMID: 29095307 DOI: 10.1097/MD.0000000000008486] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
221 Nakamura H, Hori K, Tanaka-Okamoto M, Higashiyama M, Itoh Y, Inoue M, Morinaka S, Miyoshi J. Decreased expression of LMO7 and its clinicopathological significance in human lung adenocarcinoma. Exp Ther Med 2011;2:1053-7. [PMID: 22977619 DOI: 10.3892/etm.2011.329] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
222 Fu X, Feng J, Zeng D, Ding Y, Yu C, Yang B. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways. Biosci Rep. 2014;34. [PMID: 27919028 DOI: 10.1042/bsr20130102] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
223 Yang X, Hu Y, Liu Y, Liu W, Zhao X, Liu M, Tang H. C14orf28 downregulated by miR-519d contributes to oncogenicity and regulates apoptosis and EMT in colorectal cancer. Mol Cell Biochem 2017;434:197-208. [PMID: 28455792 DOI: 10.1007/s11010-017-3049-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
224 Park TY, Na YC, Lee WH, Kim JH, Chang WS, Jung HH, Chang JH, Chang JW, Park YG. Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy. Brain Tumor Res Treat 2013;1:78-84. [PMID: 24904896 DOI: 10.14791/btrt.2013.1.2.78] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
225 Kruhøffer M, Jensen JL, Laiho P, Dyrskjøt L, Salovaara R, Arango D, Birkenkamp-Demtroder K, Sørensen FB, Christensen LL, Buhl L, Mecklin JP, Järvinen H, Thykjaer T, Wikman FP, Bech-Knudsen F, Juhola M, Nupponen NN, Laurberg S, Andersen CL, Aaltonen LA, Ørntoft TF. Gene expression signatures for colorectal cancer microsatellite status and HNPCC. Br J Cancer 2005;92:2240-8. [PMID: 15956967 DOI: 10.1038/sj.bjc.6602621] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
226 Zhou D, Mei Q, Luo H, Tang B, Yu P. The polymorphisms in methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase, and the risk of colorectal cancer. Int J Biol Sci. 2012;8:819-830. [PMID: 22719222 DOI: 10.7150/ijbs.4462] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
227 Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol. 2011;11:71. [PMID: 21669008 DOI: 10.1186/1471-230x-11-71] [Cited by in Crossref: 164] [Cited by in F6Publishing: 108] [Article Influence: 16.4] [Reference Citation Analysis]
228 Rohwer N, Lobitz S, Daskalow K, Jöns T, Vieth M, Schlag PM, Kemmner W, Wiedenmann B, Cramer T, Höcker M. HIF-1alpha determines the metastatic potential of gastric cancer cells. Br J Cancer. 2009;100:772-781. [PMID: 19223895 DOI: 10.1038/sj.bjc.6604919] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
229 Zhao J, Yu BY, Wang DY, Yang JE. Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma. World J Gastroenterol 2010;16:6104-10. [PMID: 21182225 DOI: 10.3748/wjg.v16.i48.6104] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
230 Watson NF, Madjd Z, Scrimegour D, Spendlove I, Ellis IO, Scholefield JH, Durrant LG. Evidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: a tissue microarray study of 460 patients. World J Surg Oncol. 2005;3:47. [PMID: 16029489 DOI: 10.1186/1477-7819-3-47] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
231 Huang Z, Zhang P, Wang H, Yan L, Wang W. Comparing outcomes of two vascular inflow occlusion techniques and treatment without vascular occlusion during major hepatectomy in patients with Hepatitis B-related hepatocellular carcinoma. PLoS One 2014;9:e107303. [PMID: 25203056 DOI: 10.1371/journal.pone.0107303] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
232 Xiong P, Li YX, Tang YT, Chen HG. Proteomic analyses of Sirt1-mediated cisplatin resistance in OSCC cell line. Protein J 2011;30:499-508. [PMID: 21947960 DOI: 10.1007/s10930-011-9354-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
233 Li X, Wang X, Li Z, Liu Y, Sang L, Zhang Z, Zhang Y. Expression and regulation effects of chemokine receptor 7 in colon cancer cells. Oncol Lett 2020;20:226-34. [PMID: 32565949 DOI: 10.3892/ol.2020.11561] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
234 Zhong Y, Deng M, Xu R. Reappraisal of evidence of microscopic portal vein involvement by hepatocellular carcinoma cells with stratification of tumor size. World J Surg 2015;39:1142-9. [PMID: 25270343 DOI: 10.1007/s00268-014-2807-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
235 Zhou JY, Wong DW, Ding F, Venkatesh SK, Tian Q, Qi YY, Xiong W, Liu JJ, Leow WK. Liver tumour segmentation using contrast-enhanced multi-detector CT data: performance benchmarking of three semiautomated methods. Eur Radiol. 2010;20:1738-1748. [PMID: 20157817 DOI: 10.1007/s00330-010-1712-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
236 Bjørge T, Lie AK, Hovig E, Gislefoss RE, Hansen S, Jellum E, Langseth H, Nustad K, Tropé CG, Dørum A. BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study. Br J Cancer 2004;91:1829-34. [PMID: 15477862 DOI: 10.1038/sj.bjc.6602199] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
237 Prager GW, Lackner EM, Krauth MT, Unseld M, Poettler M, Laffer S, Cerny-Reiterer S, Lamm W, Kornek GV, Binder BR, Zielinski CC, Valent P. Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab. Mol Oncol 2010;4:150-60. [PMID: 20106729 DOI: 10.1016/j.molonc.2010.01.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
238 Islam M, Sharma S, Teknos TN. RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3. PLoS One 2014;9:e88527. [PMID: 24533098 DOI: 10.1371/journal.pone.0088527] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
239 Hsu HH, Cheng LH, Ho TJ, Kuo WW, Lin YM, Chen MC, Lee NH, Tsai FJ, Tsai KH, Huang CY. Apicidin-resistant HA22T hepatocellular carcinoma cells massively promote pro-survival capability via IGF-IR/PI3K/Akt signaling pathway activation. Tumour Biol 2014;35:303-13. [PMID: 23990456 DOI: 10.1007/s13277-013-1041-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
240 Abudukadeer A, Azam S, Mutailipu AZ, Qun L, Guilin G, Mijiti S. Knowledge and attitude of Uyghur women in Xinjiang province of China related to the prevention and early detection of cervical cancer. World J Surg Oncol. 2015;13:110. [PMID: 25885660 DOI: 10.1186/s12957-015-0531-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
241 Kameda C, Nakamura M, Tanaka H, Yamasaki A, Kubo M, Tanaka M, Onishi H, Katano M. Oestrogen receptor-alpha contributes to the regulation of the hedgehog signalling pathway in ERalpha-positive gastric cancer. Br J Cancer 2010;102:738-47. [PMID: 20087349 DOI: 10.1038/sj.bjc.6605517] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
242 Chang PE, Ong WC, Lui HF, Tan CK. Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. J Gastroenterol. 2008;43:881-888. [PMID: 19012042 DOI: 10.1007/s00535-008-2238-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
243 Yeh YT, Chang CW, Wei RJ, Wang SN. Progesterone and related compounds in hepatocellular carcinoma: basic and clinical aspects. Biomed Res Int. 2013;2013:290575. [PMID: 23484104 DOI: 10.1155/2013/290575] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
244 Ghadi FE, Ghara AR, Bhattacharyya S, Dhawan DK. Selenium as a chemopreventive agent in experimentally induced colon carcinogenesis. World J Gastrointest Oncol 2009;1:74-81. [PMID: 21160778 DOI: 10.4251/wjgo.v1.i1.74] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
245 Jin YJ, Lee JW, Park SW, Lee JI, Lee DH, Kim YS, Cho SG, Jeon YS, Lee KY, Ahn SI. Survival outcome of patients with spontaneously ruptured hepatocellular carcinoma treated surgically or by transarterial embolization. World J Gastroenterol. 2013;19:4537-4544. [PMID: 23901230 DOI: 10.3748/wjg.v19.i28.4537] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
246 Ma Y, Wan Y, Luo DH, Duan LG, Li L, Xia CQ, Chen XL. Direct in vivo injection of 131I-GMS and its distribution and excretion in rabbit. World J Gastroenterol 2010;16:2120-8. [PMID: 20440852 DOI: 10.3748/wjg.v16.i17.2120] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
247 Nomura AM, Wilkens LR, Henderson BE, Epplein M, Kolonel LN. The association of cigarette smoking with gastric cancer: the multiethnic cohort study. Cancer Causes Control 2012;23:51-8. [PMID: 22037905 DOI: 10.1007/s10552-011-9854-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
248 Smith S, Fielding S, Murchie P, Johnston M, Wyke S, Powell R, Devereux G, Nicolson M, Macleod U, Wilson P, Ritchie L, Lee AJ, Campbell NC. Reducing the time before consulting with symptoms of lung cancer: a randomised controlled trial in primary care. Br J Gen Pract 2013;63:e47-54. [PMID: 23336469 DOI: 10.3399/bjgp13X660779] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 4.1] [Reference Citation Analysis]
249 Shoji K, Oda K, Kashiyama T, Ikeda Y, Nakagawa S, Sone K, Miyamoto Y, Hiraike H, Tanikawa M, Miyasaka A, Koso T, Matsumoto Y, Wada-Hiraike O, Kawana K, Kuramoto H, McCormick F, Aburatani H, Yano T, Kozuma S, Taketani Y. Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas. PLoS One 2012;7:e37431. [PMID: 22662154 DOI: 10.1371/journal.pone.0037431] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
250 Duncan TJ, Watson NF, Al-Attar AH, Scholefield JH, Durrant LG. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer. World J Surg Oncol. 2007;5:31. [PMID: 17349047 DOI: 10.1186/1477-7819-5-31] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
251 Chen H, Fang Y, Zhu H, Li S, Wang T, Gu P, Fang X, Wu Y, Liang J, Zeng Y, Zhang L, Qiu W, Zhang L, Yi X. Protein-protein interaction analysis of distinct molecular pathways in two subtypes of colorectal carcinoma. Mol Med Rep 2014;10:2868-74. [PMID: 25242495 DOI: 10.3892/mmr.2014.2585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
252 Gao J, Li L, Wu M, Liu M, Xie X, Guo J, Tang H, Xie X. MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1. PLoS One 2013;8:e65138. [PMID: 23750239 DOI: 10.1371/journal.pone.0065138] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 8.9] [Reference Citation Analysis]
253 Levidou G, Korkolopoulou P, Nikiteas N, Tzanakis N, Thymara I, Saetta AA, Tsigris C, Rallis G, Vlasis K, Patsouris E. Expression of Nuclear Factor κB in Human Gastric Carcinoma: Relationship with IκBa and Prognostic Significance. Virchows Archiv. 2007;450:519-527. [PMID: 17429689 DOI: 10.1007/s00428-007-0396-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
254 Coenen A, Honda O, van der Jagt EJ, Tomiyama N. Computer-assisted solid lung nodule 3D volumetry on CT: influence of scan mode and iterative reconstruction: a CT phantom study. Jpn J Radiol 2013;31:677-84. [PMID: 23955317 DOI: 10.1007/s11604-013-0235-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
255 Zhang X, Chang A. Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer. J Med Genet 2007;44:166-72. [PMID: 17158592 DOI: 10.1136/jmg.2006.046102] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
256 Johnson S, Koh WP, Wang R, Govindarajan S, Yu MC, Yuan JM. Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Cancer Causes Control 2011;22:503-10. [PMID: 21258859 DOI: 10.1007/s10552-010-9725-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
257 Harris JE Jr, Shin J, Lee B, Pelosky K, Hooker CM, Harbom K, Hulbert A, Zahnow C, Yang SC, Baylin S, Brayton C, Brock MV. A murine xenograft model of spontaneous metastases of human lung adenocarcinoma. J Surg Res 2011;171:e75-9. [PMID: 21872887 DOI: 10.1016/j.jss.2011.06.058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
258 Zhu SC, Liu YH, Wei Y, Li LL, Dou SW, Sun TY, Shi DP. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging. World J Gastroenterol. 2018;24:929-940. [PMID: 29491686 DOI: 10.3748/wjg.v24.i8.929] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
259 Guevara-López U, Altamirano-Bustamante MM, Viesca-Treviño C. New frontiers in the future of palliative care: real-world bioethical dilemmas and axiology of clinical practice. BMC Med Ethics 2015;16:11. [PMID: 25890355 DOI: 10.1186/s12910-015-0003-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
260 Deng X, Liang J, Jiang M, Zhou X, Liu H. Association between the C.1161G>A and C.1779C>G genetic variants of XRCC1 gene and hepatocellular carcinoma risk in Chinese population. Int J Biol Sci 2013;9:289-94. [PMID: 23493666 DOI: 10.7150/ijbs.5928] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
261 Giannini EG, Cucchetti A, Erroi V, Garuti F, Odaldi F, Trevisani F. Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it? World J Gastroenterol. 2013;19:8808-8821. [PMID: 24379604 DOI: 10.3748/wjg.v19.i47.8808] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
262 Carden CP, Stewart A, Thavasu P, Kipps E, Pope L, Crespo M, Miranda S, Attard G, Garrett MD, Clarke PA, Workman P, de Bono JS, Gore M, Kaye SB, Banerji U. The association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer. Mol Cancer Ther 2012;11:1609-17. [PMID: 22556379 DOI: 10.1158/1535-7163.MCT-11-0996] [Cited by in Crossref: 55] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]
263 Sanjoaquin MA, Appleby PN, Thorogood M, Mann JI, Key TJ. Nutrition, lifestyle and colorectal cancer incidence: a prospective investigation of 10998 vegetarians and non-vegetarians in the United Kingdom. Br J Cancer. 2004;90:118-121. [PMID: 14710217 DOI: 10.1038/sj.bjc.6601441] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 4.8] [Reference Citation Analysis]
264 Hernandez AL, Karthik R, Sivasubramanian M, Raghavendran A, Lensing S, Lee JY, Abraham P, Mathai D, Palefsky JM. Prevalence of oral human papillomavirus infection among Indian HIV-positive men who have sex with men: a cross-sectional study. BMC Infect Dis 2021;21:675. [PMID: 34247583 DOI: 10.1186/s12879-021-06301-6] [Reference Citation Analysis]
265 Yang Y, Wang C, Lu Y, Bai W, An L, Qu J, Gao X, Chen Y, Zhou L, Wu Y, Feng Y, Zhang M, Chang X, Lv J. Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2012;19:674-84. [PMID: 22187145 DOI: 10.1007/s00534-011-0490-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
266 Wong J, Schulman A, Kelly K, Zamarin D, Palese P, Fong Y. Detection of free peritoneal cancer cells in gastric cancer using cancer-specific Newcastle disease virus. J Gastrointest Surg. 2010;14:7-14. [PMID: 19902312 DOI: 10.1007/s11605-009-1071-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
267 Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol. 2007;42:1-15. [PMID: 17322988 DOI: 10.1007/s00535-006-1990-z] [Cited by in Crossref: 113] [Cited by in F6Publishing: 102] [Article Influence: 8.1] [Reference Citation Analysis]
268 Shrubsole MJ, Shu XO, Li HL, Cai H, Yang G, Gao YT, Gao J, Zheng W. Dietary B vitamin and methionine intakes and breast cancer risk among Chinese women. Am J Epidemiol 2011;173:1171-82. [PMID: 21447479 DOI: 10.1093/aje/kwq491] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
269 Zhang JL, Liu M, Yang Q, Lin SY, Shan HB, Wang HY, Xu GL. Effects of omeprazole in improving concurrent chemoradiotherapy efficacy in rectal cancer. World J Gastroenterol 2017;23:2575-84. [PMID: 28465642 DOI: 10.3748/wjg.v23.i14.2575] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
270 Zheng HC, Li YL, Sun JM, Yang XF, Li XH, Jiang WG, Zhang YC, Xin Y. Growth, invasion, metastasis, differentiation, angiogenesis and apoptosis of gastric cancer regulated by expression of PTEN encoding products. World J Gastroenterol. 2003;9:1662-1666. [PMID: 12918097 DOI: 10.3748/wjg.v9.i8.1662] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
271 Zou B, Zhou XL, Lai SQ, Liu JC. Notch signaling and non-small cell lung cancer. Oncol Lett 2018;15:3415-21. [PMID: 29467866 DOI: 10.3892/ol.2018.7738] [Cited by in Crossref: 8] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
272 Feng W, Xue T, Huang S, Shi Q, Tang C, Cui G, Yang G, Gong H, Guo H. HIF-1α promotes the migration and invasion of hepatocellular carcinoma cells via the IL-8-NF-κB axis. Cell Mol Biol Lett 2018;23:26. [PMID: 29881400 DOI: 10.1186/s11658-018-0077-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
273 Na II, Rho JK, Choi YJ, Kim CH, Koh JS, Ryoo BY, Yang SH, Lee JC. Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer. J Korean Med Sci 2007;22:393-9. [PMID: 17596643 DOI: 10.3346/jkms.2007.22.3.393] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
274 Cai W, Gao T, Hong H, Sun J. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl 2008;1:17-32. [PMID: 24198458 DOI: 10.2147/nsa.s3788] [Cited by in Crossref: 481] [Cited by in F6Publishing: 104] [Article Influence: 37.0] [Reference Citation Analysis]
275 Chung YL, Wu ML. Dual oncogenic and tumor suppressor roles of the promyelocytic leukemia gene in hepatocarcinogenesis associated with hepatitis B virus surface antigen. Oncotarget 2016;7:28393-407. [PMID: 27058621 DOI: 10.18632/oncotarget.8613] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
276 Yang Y, Xia T, Li N, Zhang J, Yang Y, Cong W, Deng Q, Lan K, Zhou W. Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma. Protein Cell 2013;4:71-81. [PMID: 23292895 DOI: 10.1007/s13238-012-2067-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
277 Pourhoseingholi MA, Zali MR. Colorectal cancer screening: Time for action in Iran. World J Gastrointest Oncol. 2012;4:82-83. [PMID: 22532881 DOI: 10.4251/wjgo.v4.i4.82] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
278 Tazaki E, Shimizu N, Tanaka R, Yoshizumi M, Kamma H, Imoto S, Goya T, Kozawa K, Nishina A, Kimura H. Serum cytokine profiles in patients with prostate carcinoma. Exp Ther Med 2011;2:887-91. [PMID: 22977593 DOI: 10.3892/etm.2011.286] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
279 Mu Y, Su X. Polymorphism in pre-miR-30c contributes to gastric cancer risk in a Chinese population. Med Oncol 2012;29:1723-32. [DOI: 10.1007/s12032-011-0115-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
280 Albeldawi M, Soliman M, Lopez R, Zein NN. Hepatitis C virus-associated primary hepatocellular carcinoma in non-cirrhotic patients. Dig Dis Sci. 2012;57:3265-3270. [PMID: 22695885 DOI: 10.1007/s10620-012-2260-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
281 Feng H, Cheng AS, Tsang DP, Li MS, Go MY, Cheung YS, Zhao GJ, Ng SS, Lin MC, Yu J. Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis. J Clin Invest. 2011;121:3159-3175. [PMID: 21747169 DOI: 10.1172/jci45967] [Cited by in Crossref: 82] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
282 Lu Y, Xu YC, Shen J, Yu RB, Niu JY, Guo JT, Hu X, Shen HB. E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population. World J Gastroenterol. 2005;11:56-60. [PMID: 15609397 DOI: 10.3748/wjg.v11.i1.56] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
283 Lin JK, Tan EC, Yang MC. Comparing the effectiveness of capecitabine versus 5-fluorouracil/leucovorin therapy for elderly Taiwanese stage III colorectal cancer patients based on quality-of-life measures (QLQ-C30 and QLQ-CR38) and a new cost assessment tool. Health Qual Life Outcomes 2015;13:61. [PMID: 25986478 DOI: 10.1186/s12955-015-0261-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
284 Yan PG, Wang RY, Zhang J, Cong WM, Dong H, Yu HY, Lau WY, Wu MC, Zhou WP. Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study. J Gastrointest Surg 2018;22:872-83. [PMID: 29313290 DOI: 10.1007/s11605-017-3638-0] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
285 Sun Y, Zang Z, Xu X, Zhang Z, Zhong L, Zan W, Zhao Y, Sun L. Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry. Int J Mol Sci 2010;11:1423-33. [PMID: 20480028 DOI: 10.3390/ijms11041423] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
286 Shi XJ, Wei Y, Ji B. Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment.Front Mol Biosci. 2020;7:203. [PMID: 33005629 DOI: 10.3389/fmolb.2020.00203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
287 Koeberle D, Montemurro M, Samaras P, Majno P, Simcock M, Limacher A, Lerch S, Kovàcs K, Inauen R, Hess V. Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06). Oncologist. 2010;15:285-292. [PMID: 20203173 DOI: 10.1634/theoncologist.2009-0316] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.2] [Reference Citation Analysis]
288 Xia L, Gong Y, Zhang A, Cai S, Zeng Q. Loss of GATA5 expression due to gene promoter methylation induces growth and colony formation of hepatocellular carcinoma cells. Oncol Lett 2016;11:861-9. [PMID: 26870297 DOI: 10.3892/ol.2015.3974] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
289 Nouso K, Ito Y, Kuwaki K, Kobayashi Y, Nakamura S, Ohashi Y, Yamamoto K. Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis. Br J Cancer. 2008;98:1161-1165. [PMID: 18349849 DOI: 10.1038/sj.bjc.6604282] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
290 Renz BW, Thasler WE, Preissler G, Heide T, Khalil PN, Mikhailov M, Jauch KW, Kreis ME, Rentsch M, Kleespies A. Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis. J Gastrointest Surg. 2013;17:981-990. [PMID: 23475629 DOI: 10.1007/s11605-013-2171-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
291 Dong Y, Shi Q, Pai HC, Peng CY, Pan SL, Teng CM, Nakagawa-Goto K, Yu D, Liu YN, Wu PC, Bastow KF, Morris-Natschke SL, Brossi A, Lang JY, Hsu JL, Hung MC, Lee EY, Lee KH. Antitumor agents. 272. Structure-activity relationships and in vivo selective anti-breast cancer activity of novel neo-tanshinlactone analogues. J Med Chem 2010;53:2299-308. [PMID: 20148565 DOI: 10.1021/jm1000858] [Cited by in Crossref: 53] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
292 Wang LK, Xie XN, Song XH, Su T, Chang XL, Xu M, Liang B, Huang DY. Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein. Technol Cancer Res Treat 2018;17:1533033818806475. [PMID: 30343649 DOI: 10.1177/1533033818806475] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
293 Bertino G, Ardiri A, Demma S, GiuseppeCalvagno S, Toro A, Basile E, Campagna D, Ferraro G, Frazzetto E, Proiti M. Rare benign tumors of the liver: still rare? J Gastrointest Cancer. 2014;45:202-217. [PMID: 24510731 DOI: 10.1007/s12029-014-9580-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
294 Chai J, Wang S, Han D, Dong W, Xie C, Guo H. MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase. Tumour Biol. 2015;36:1313-1321. [PMID: 25355599 DOI: 10.1007/s13277-014-2766-3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
295 Chen HM, Lee MJ, Kuo CY, Tsai PL, Liu JY, Kao SH. Ocimum gratissimum Aqueous Extract Induces Apoptotic Signalling in Lung Adenocarcinoma Cell A549. Evid Based Complement Alternat Med 2011;2011:739093. [PMID: 20953389 DOI: 10.1155/2011/739093] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
296 Jiang YA, Luo HS, Fan LF, Jiang CQ, Chen WJ. Effect of antisense oligodeoxynucleotide of telomerase RNA on telomerase activity and cell apoptosis in human colon cancer. World J Gastroenterol 2004;10:443-5. [PMID: 14760776 DOI: 10.3748/wjg.v10.i3.443] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
297 Zhu Y, Gu L, Chen T, Zheng G, Ye C, Jia W. Factors influencing early recurrence of hepatocellular carcinoma after curative resection. J Int Med Res 2020;48:300060520945552. [PMID: 33106072 DOI: 10.1177/0300060520945552] [Reference Citation Analysis]
298 Tanoue S, Chang LY, Li Y, Kaplan DE. Monocyte-derived dendritic cells from cirrhotic patients retain similar capacity for maturation/activation and antigen presentation as those from healthy subjects. Cell Immunol 2015;295:36-45. [PMID: 25734547 DOI: 10.1016/j.cellimm.2015.02.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
299 Park SJ, Kim CH, Kim JD, Um SH, Yim SY, Seo MH, Lee DI, Kang JH, Keum B, Kim YS. Spinal cord injury after conducting transcatheter arterial chemoembolization for costal metastasis of hepatocellular carcinoma. Clin Mol Hepatol. 2012;18:316-320. [PMID: 23091813 DOI: 10.3350/cmh.2012.18.3.316] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
300 Ananthi S, Lakshmi CNP, Atmika P, Anbarasu K, Mahalingam S. Global Quantitative Proteomics reveal Deregulation of Cytoskeletal and Apoptotic Signalling Proteins in Oral Tongue Squamous Cell Carcinoma. Sci Rep 2018;8:1567. [PMID: 29371635 DOI: 10.1038/s41598-018-19937-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
301 Jin F, Xiong WJ, Jing JC, Feng Z, Qu LS, Shen XZ. Evaluation of the association studies of single nucleotide polymorphisms and hepatocellular carcinoma: a systematic review. J Cancer Res Clin Oncol. 2011;137:1095-1104. [PMID: 21240526 DOI: 10.1007/s00432-010-0970-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
302 Mokarram P, Kumar K, Brim H, Naghibalhossaini F, Saberi-firoozi M, Nouraie M, Green R, Lee E, Smoot DT, Ashktorab H. Distinct high-profile methylated genes in colorectal cancer. PLoS One. 2009;4:e7012. [PMID: 19750230 DOI: 10.1371/journal.pone.0007012] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 7.7] [Reference Citation Analysis]
303 Carvalho Barbosa Rde C, Menezes DC, Freire TF, Sales DC, Alencar VH, Rabenhorst SH. Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent. Mol Biol Rep 2012;39:4899-907. [PMID: 22134752 DOI: 10.1007/s11033-011-1285-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
304 Bodalal Z, Bendardaf R. Colorectal carcinoma in a Southern Mediterranean country: The Libyan scenario. World J Gastrointest Oncol 2014;6:98-103. [PMID: 24734155 DOI: 10.4251/wjgo.v6.i4.98] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
305 Dai D, Oyana TJ. Spatial variations in the incidence of breast cancer and potential risks associated with soil dioxin contamination in Midland, Saginaw, and Bay Counties, Michigan, USA. Environ Health 2008;7:49. [PMID: 18939976 DOI: 10.1186/1476-069X-7-49] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
306 Tan X, Liao L, Wan YP, Li MX, Chen SH, Mo WJ, Zhao QL, Huang LF, Zeng GQ. Downregulation of selenium-binding protein 1 is associated with poor prognosis in lung squamous cell carcinoma. World J Surg Oncol 2016;14:70. [PMID: 26956891 DOI: 10.1186/s12957-016-0832-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
307 Wang C, Lu Y, Wang H, Gao X, Bai W, Qu J, Xu G, Zhang Z, Zeng Z, Zhou L, An L, Lv J, Yang Y. Transarterial chemoembolization with/without cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma. Exp Ther Med 2012;4:188-96. [PMID: 23139708 DOI: 10.3892/etm.2012.569] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
308 Wu Y, Zhu Y, Li S, Zeng M, Chu J, Hu P, Li J, Guo Q, Lv XB, Huang G. Terrein performs antitumor functions on esophageal cancer cells by inhibiting cell proliferation and synergistic interaction with cisplatin. Oncol Lett 2017;13:2805-10. [PMID: 28454470 DOI: 10.3892/ol.2017.5758] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
309 Han K, Bezjak A, Xu W, Kane G. Has the practice of radiation oncology for locally advanced and metastatic non-small-cell lung cancer changed in Canada? Curr Oncol 2010;17:33-40. [PMID: 20179801 DOI: 10.3747/co.v17i1.387] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
310 Aftab U, Zechel DL, Sajid I. Antitumor compounds from Streptomyces sp. KML-2, isolated from Khewra salt mines, Pakistan. Biol Res 2015;48:58. [PMID: 26466995 DOI: 10.1186/s40659-015-0046-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
311 Jung N, Won JK, Kim BH, Suh KS, Jang JJ, Kang GH. Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma. J Korean Med Sci 2012;27:594-604. [PMID: 22690089 DOI: 10.3346/jkms.2012.27.6.594] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
312 Liang Y, Chen M, Qin L, Wan B, Wang H. A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia. Infect Agent Cancer 2019;14:29. [PMID: 31673281 DOI: 10.1186/s13027-019-0243-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
313 Saunier M, Monnier-Benoit S, Mauny F, Dalstein V, Briolat J, Riethmuller D, Kantelip B, Schwarz E, Mougin C, Prétet JL. Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J Clin Microbiol 2008;46:3678-85. [PMID: 18799702 DOI: 10.1128/JCM.01212-08] [Cited by in Crossref: 60] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
314 Attia F, Fathy S, Anani M, Hassan A, Attia F, Ibrahim G, Elazab M. Human equilibrative nucleoside transporter-1 and deoxycytidine kinase can predict gemcitabine effectiveness in Egyptian patients with Hepatocellular carcinoma. J Clin Lab Anal 2020;34:e23457. [PMID: 32671914 DOI: 10.1002/jcla.23457] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
315 Ding X, Wang K, Wang H, Zhang G, Liu Y, Yang Q, Chen W, Hu S. High expression of CCL20 is associated with poor prognosis in patients with hepatocellular carcinoma after curative resection. J Gastrointest Surg. 2012;16:828-836. [PMID: 22072303 DOI: 10.1007/s11605-011-1775-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
316 Na II, Park JH, Choe du H, Lee JK, Koh JS. Association of epidermal growth factor receptor mutations with metastatic presentations in non-small cell lung cancer. ISRN Oncol 2011;2011:756265. [PMID: 22091430 DOI: 10.5402/2011/756265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
317 Iwagami Y, Huang CK, Olsen MJ, Thomas JM, Jang G, Kim M, Lin Q, Carlson RI, Wagner CE, Dong X, Wands JR. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma. Hepatology 2016;63:1213-26. [PMID: 26683595 DOI: 10.1002/hep.28411] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
318 Cervigne NK, Machado J, Goswami RS, Sadikovic B, Bradley G, Perez-Ordonez B, Galloni NN, Gilbert R, Gullane P, Irish JC, Jurisica I, Reis PP, Kamel-Reid S. Recurrent genomic alterations in sequential progressive leukoplakia and oral cancer: drivers of oral tumorigenesis? Hum Mol Genet 2014;23:2618-28. [PMID: 24403051 DOI: 10.1093/hmg/ddt657] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
319 Del Carmen S, Sayagués JM, Bengoechea O, Anduaga MF, Alcazar JA, Gervas R, García J, Orfao A, Bellvis LM, Sarasquete ME, Del Mar Abad M. Spatio-temporal tumor heterogeneity in metastatic CRC tumors: a mutational-based approach. Oncotarget 2018;9:34279-88. [PMID: 30344942 DOI: 10.18632/oncotarget.26081] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
320 Hoenerhoff MJ, Pandiri AR, Lahousse SA, Hong HH, Ton TV, Masinde T, Auerbach SS, Gerrish K, Bushel PR, Shockley KR, Peddada SD, Sills RC. Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer. Toxicol Pathol 2011;39:678-99. [PMID: 21571946 DOI: 10.1177/0192623311407213] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
321 Islam M, Lin G, Brenner JC, Pan Q, Merajver SD, Hou Y, Kumar P, Teknos TN. RhoC expression and head and neck cancer metastasis. Mol Cancer Res 2009;7:1771-80. [PMID: 19861405 DOI: 10.1158/1541-7786.MCR-08-0512] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
322 Balunas MJ, Su B, Brueggemeier RW, Kinghorn AD. Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity. J Nat Prod 2008;71:1161-6. [PMID: 18558747 DOI: 10.1021/np8000255] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
323 Ma R, Xu H, Wu J, Sharma A, Bai S, Dun B, Jing C, Cao H, Wang Z, She JX, Feng J. Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer. Oncotarget 2017;8:18901-13. [PMID: 28121629 DOI: 10.18632/oncotarget.14782] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
324 Luo X, Ding Q, Wang M, Li Z, Mao K, Sun B, Pan Y, Wang Z, Zang YQ, Chen Y. In vivo disruption of TGF-beta signaling by Smad7 in airway epithelium alleviates allergic asthma but aggravates lung carcinogenesis in mouse. PLoS One 2010;5:e10149. [PMID: 20405019 DOI: 10.1371/journal.pone.0010149] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
325 Lauand C, Rezende-Teixeira P, Cortez BA, Niero EL, Machado-Santelli GM. Independent of ErbB1 gene copy number, EGF stimulates migration but is not associated with cell proliferation in non-small cell lung cancer. Cancer Cell Int 2013;13:38. [PMID: 23631593 DOI: 10.1186/1475-2867-13-38] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
326 Wang J, Kuo YF, Freeman J, Markowitz AB, Goodwin JS. Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer. Cancer 2008;112:382-90. [PMID: 18041068 DOI: 10.1002/cncr.23181] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
327 Galletti G, Zhang C, Gjyrezi A, Cleveland K, Zhang J, Powell S, Thakkar PV, Betel D, Shah MA, Giannakakou P. Microtubule Engagement with Taxane Is Altered in Taxane-Resistant Gastric Cancer. Clin Cancer Res 2020;26:3771-83. [PMID: 32321717 DOI: 10.1158/1078-0432.CCR-19-3018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
328 Odutola M, Jedy-Agba EE, Dareng EO, Oga EA, Igbinoba F, Otu T, Ezeome E, Hassan R, Adebamowo CA. Burden of Cancers Attributable to Infectious Agents in Nigeria: 2012-2014. Front Oncol 2016;6:216. [PMID: 27822455 DOI: 10.3389/fonc.2016.00216] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
329 Liu S, Gong J, Morishita A, Nomura T, Miyoshi H, Tani J, Kato K, Yoneyama H, Deguchi A, Mori H, Mimura S, Nomura K, Himoto T, Deguchi K, Okano K, Izuishi K, Suzuki Y, Kushida Y, Haba R, Iwama H, Masaki T. Use of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinoma. Exp Ther Med 2011;2:399-403. [PMID: 22977516 DOI: 10.3892/etm.2011.215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
330 Lindblad M, García Rodríguez LA, Chandanos E, Lagergren J. Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer 2006;94:136-41. [PMID: 16404367 DOI: 10.1038/sj.bjc.6602906] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 4.2] [Reference Citation Analysis]
331 Revill PA, Tu T, Netter HJ, Yuen LKW, Locarnini SA, Littlejohn M. The evolution and clinical impact of hepatitis B virus genome diversity. Nat Rev Gastroenterol Hepatol 2020;17:618-34. [DOI: 10.1038/s41575-020-0296-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 20.0] [Reference Citation Analysis]
332 Xu D, Jin G, Chai D, Zhou X, Gu W, Chong Y, Song J, Zheng J. The development of CAR design for tumor CAR-T cell therapy. Oncotarget 2018;9:13991-4004. [PMID: 29568411 DOI: 10.18632/oncotarget.24179] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
333 Trigonis I, Koh PK, Taylor B, Tamal M, Ryder D, Earl M, Anton-Rodriguez J, Haslett K, Young H, Faivre-Finn C, Blackhall F, Jackson A, Asselin MC. Early reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone. Eur J Nucl Med Mol Imaging 2014;41:682-93. [PMID: 24504503 DOI: 10.1007/s00259-013-2632-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
334 Yang Y, Lu Y, Wang C, Bai W, Qu J, Chen Y, Chang X, An L, Zhou L, Zeng Z. Cryotherapy is associated with improved clinical outcomes of Sorafenib therapy for advanced hepatocellular carcinoma. Cell Biochem Biophys. 2012;63:159-169. [PMID: 22477032 DOI: 10.1007/s12013-012-9353-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
335 Ow TJ, Myers JN. Current management of advanced resectable oral cavity squamous cell carcinoma. Clin Exp Otorhinolaryngol 2011;4:1-10. [PMID: 21461056 DOI: 10.3342/ceo.2011.4.1.1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
336 Agarwal G, Ramakant P. Breast Cancer Care in India: The Current Scenario and the Challenges for the Future. Breast Care (Basel) 2008;3:21-7. [PMID: 20824016 DOI: 10.1159/000115288] [Cited by in Crossref: 103] [Cited by in F6Publishing: 46] [Article Influence: 7.9] [Reference Citation Analysis]
337 Xynos ID, Kavantzas N, Tsaousi S, Zacharakis M, Agrogiannis G, Kosmas C, Lazaris A, Sarantonis J, Sougioultzis S, Tzivras D, Polyzos A, Patsouris ES, Tsavaris N. Factors Influencing Survival in Stage IV Colorectal Cancer: The Influence of DNA Ploidy. ISRN Gastroenterol 2013;2013:490578. [PMID: 23840958 DOI: 10.1155/2013/490578] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
338 Sandouk F, Al Jerf F, Al-Halabi MH. Precancerous lesions in colorectal cancer. Gastroenterol Res Pract. 2013;2013:457901. [PMID: 23737765 DOI: 10.1155/2013/457901] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
339 Shen XF, Zeng XT, Jian ZY, Zhou M, Zhou P, Zhang M. Quantitative assessment of the effect of epidermal growth factor 61A/G polymorphism on the risk of hepatocellular carcinoma. Oncol Lett 2015;10:3199-205. [PMID: 26722312 DOI: 10.3892/ol.2015.3723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
340 Ohta H, Aoyagi K, Fukaya M, Danjoh I, Ohta A, Isohata N, Saeki N, Taniguchi H, Sakamoto H, Shimoda T. Cross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers. Br J Cancer. 2009;100:389-398. [PMID: 19107131 DOI: 10.1038/sj.bjc.6604846] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 5.4] [Reference Citation Analysis]
341 Yan L, Huang H, Zhang Y, Yuan X, Yan Z, Cao C, Luo X. Involvement of p53-dependent apoptosis signal in antitumor effect of Colchicine on human papilloma virus (HPV)-positive human cervical cancer cells. Biosci Rep 2020;40:BSR20194065. [PMID: 32163135 DOI: 10.1042/BSR20194065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
342 Su K, Hu P, Wang X, Kuang C, Xiang Q, Yang F, Xiang J, Zhu S, Wei L, Zhang J. Tumor suppressor berberine binds VASP to inhibit cell migration in basal-like breast cancer. Oncotarget. 2016;7:45849-45862. [PMID: 27322681 DOI: 10.18632/oncotarget.9968] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
343 Tufail K, Araya V, Azhar A, Hertzog D, Khanmoradi K, Ortiz J. Paraparesis caused by transarterial chemoembolization: A case report. World J Hepatol. 2010;2:289-291. [PMID: 21161010 DOI: 10.4254/wjh.v2.i7.289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
344 Zhang C, Xiao W, Chen K, Zhang Z, Du G, Jiang E, Yang H. A new intracorporeal Billroth II stapled anastomosis technique in totally laparoscopic distal gastrectomy. Surg Endosc 2015;29:1636-42. [PMID: 25270612 DOI: 10.1007/s00464-014-3825-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
345 Hu M, Zhao G, Xu D, Liu R. Laparoscopic repeat resection of recurrent hepatocellular carcinoma. World J Surg. 2011;35:648-655. [PMID: 21184074 DOI: 10.1007/s00268-010-0919-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
346 Datta J, Islam M, Dutta S, Roy S, Pan Q, Teknos TN. Suberoylanilide hydroxamic acid inhibits growth of head and neck cancer cell lines by reactivation of tumor suppressor microRNAs. Oral Oncol 2016;56:32-9. [PMID: 27086484 DOI: 10.1016/j.oraloncology.2016.02.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
347 Miwa K, Oki E, Emi Y, Saeki H, Kusumoto T, Akagi Y, Ogata Y, Samura H, Tokunaga S, Ishikawa H, Tanaka T, Sueyoshi S, Higashi H, Matsuda H, Touyama T, Maehara Y; Kyushu Study Group of Clinical Cancer. Phase II trial of an alternating regimen consisting of first-line mFOLFOX6 plus bevacizumab and FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: FIREFOX plus bevacizumab trial (KSCC0801). Int J Clin Oncol 2016;21:110-7. [PMID: 26037783 DOI: 10.1007/s10147-015-0850-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
348 Shim JH, Park J, Choi J, Park BJ, Kim C. Practical efficacy of sorafenib monotherapy for advanced hepatocellular carcinoma patients in a Hepatitis B virus-endemic area. J Cancer Res Clin Oncol 2009;135:617-25. [DOI: 10.1007/s00432-008-0496-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
349 Ben S, Du M, Ma G, Qu J, Zhu L, Chu H, Zhang Z, Wu Y, Gu D, Wang M. Vitamin B2 intake reduces the risk for colorectal cancer: a dose-response analysis. Eur J Nutr 2019;58:1591-602. [PMID: 29744609 DOI: 10.1007/s00394-018-1702-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
350 Oh JD, Kling-Bäckhed H, Giannakis M, Xu J, Fulton RS, Fulton LA, Cordum HS, Wang C, Elliott G, Edwards J, Mardis ER, Engstrand LG, Gordon JI. The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. Proc Natl Acad Sci U S A 2006;103:9999-10004. [PMID: 16788065 DOI: 10.1073/pnas.0603784103] [Cited by in Crossref: 179] [Cited by in F6Publishing: 172] [Article Influence: 11.9] [Reference Citation Analysis]
351 Takeishi K, Shirabe K, Muto J, Toshima T, Taketomi A, Maehara Y. Clinicopathological features and outcomes of young patients with hepatocellular carcinoma after hepatectomy. World J Surg 2011;35:1063-71. [PMID: 21380583 DOI: 10.1007/s00268-011-1017-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
352 Mitry E, Rachet B, Quinn MJ, Cooper N, Coleman MP. Survival from cancer of the stomach in England and Wales up to 2001. Br J Cancer 2008;99 Suppl 1:S16-8. [PMID: 18813246 DOI: 10.1038/sj.bjc.6604574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
353 Guo AY, Liang XJ, Liu RJ, Li XX, Bi W, Zhou LY, Tang CE, Yan A, Chen ZC, Zhang PF. Flotilin-1 promotes the tumorigenicity and progression of malignant phenotype in human lung adenocarcinoma. Cancer Biol Ther 2017;18:715-22. [PMID: 28825855 DOI: 10.1080/15384047.2017.1360445] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
354 Tavakoli H, Robinson A, Liu B, Bhuket T, Younossi Z, Saab S, Ahmed A, Wong RJ. Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma. Dig Dis Sci. 2017;62:2174-2181. [PMID: 28474143 DOI: 10.1007/s10620-017-4595-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
355 Wang W, Iyer NG, Tay HT, Wu Y, Lim TK, Zheng L, Song IC, Kwoh CK, Huynh H, Tan PO, Chow PK. Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma. BMC Cancer 2015;15:828. [PMID: 26520397 DOI: 10.1186/s12885-015-1814-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
356 Sawai H, Nishida N, Khor SS, Honda M, Sugiyama M, Baba N, Yamada K, Sawada N, Tsugane S, Koike K, Kondo Y, Yatsuhashi H, Nagaoka S, Taketomi A, Fukai M, Kurosaki M, Izumi N, Kang JH, Murata K, Hino K, Nishina S, Matsumoto A, Tanaka E, Sakamoto N, Ogawa K, Yamamoto K, Tamori A, Yokosuka O, Kanda T, Sakaida I, Itoh Y, Eguchi Y, Oeda S, Mochida S, Yuen MF, Seto WK, Poovorawan Y, Posuwan N, Mizokami M, Tokunaga K. Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma. Sci Rep 2018;8:7958. [PMID: 29784950 DOI: 10.1038/s41598-018-26217-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
357 Yong-Deok K, Eun-Hyoung J, Yeon-Sun K, Kang-Mi P, Jin-Yong L, Sung-Hwan C, Tae-Yun K, Tae-Sung P, Soung-Min K, Myung-Jin K, Jong-Ho L. Molecular genetic study of novel biomarkers for early diagnosis of oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2015;20:e167-79. [PMID: 25475780 DOI: 10.4317/medoral.20229] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
358 Sawai H, Nishida N, Mbarek H, Matsuda K, Mawatari Y, Yamaoka M, Hige S, Kang JH, Abe K, Mochida S, Watanabe M, Kurosaki M, Asahina Y, Izumi N, Honda M, Kaneko S, Tanaka E, Matsuura K, Itoh Y, Mita E, Korenaga M, Hino K, Murawaki Y, Hiasa Y, Ide T, Ito K, Sugiyama M, Ahn SH, Han KH, Park JY, Yuen MF, Nakamura Y, Tanaka Y, Mizokami M, Tokunaga K. No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations. BMC Med Genet. 2012;13:47. [PMID: 22712471 DOI: 10.1186/1471-2350-13-47] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
359 Freire P, Portela F, Donato MM, Figueiredo P, Ferreira M, Amaro P, Sá A, Andrade P, Gouveia H, Sofia C. CARD15 mutations and colorectal cancer in a South European country. Int J Colorectal Dis. 2010;25:1211-1219. [PMID: 20676658 DOI: 10.1007/s00384-010-1028-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
360 Yokomine K, Senju S, Nakatsura T, Irie A, Hayashida Y, Ikuta Y, Harao M, Imai K, Baba H, Iwase H, Nomori H, Takahashi K, Daigo Y, Tsunoda T, Nakamura Y, Sasaki Y, Nishimura Y. The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy. Int J Cancer 2010;126:2153-63. [PMID: 19688828 DOI: 10.1002/ijc.24836] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
361 Jou J, Diehl AM. Epithelial-mesenchymal transitions and hepatocarcinogenesis. J Clin Invest. 2010;120:1031-1034. [PMID: 20335655 DOI: 10.1172/JCI42615] [Cited by in Crossref: 71] [Cited by in F6Publishing: 40] [Article Influence: 6.5] [Reference Citation Analysis]
362 Wu X, Yang T, Liu X, Guo JN, Xie T, Ding Y, Lin M, Yang H. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer. Tumour Biol. 2016;37:5493-5501. [PMID: 26566627 DOI: 10.1007/s13277-015-4372] [Reference Citation Analysis]
363 Yang LL, Liu BC, Lu XY, Yan Y, Zhai YJ, Bao Q, Doetsch PW, Deng X, Thai TL, Alli AA, Eaton DC, Shen BZ, Ma HP. Inhibition of TRPC6 reduces non-small cell lung cancer cell proliferation and invasion. Oncotarget 2017;8:5123-34. [PMID: 28030826 DOI: 10.18632/oncotarget.14034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
364 Aktas Z, Gunay E, Hoca NT, Yilmaz A, Demirag F, Gunay S, Sipit T, Kurt EB. Endobronchial cryobiopsy or forceps biopsy for lung cancer diagnosis. Ann Thorac Med 2010;5:242-6. [PMID: 20981186 DOI: 10.4103/1817-1737.69117] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
365 Takeishi K, Kawanaka H, Itoh S, Harimoto N, Ikegami T, Yoshizumi T, Shirabe K, Maehara Y. Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy. World J Surg 2018;42:1120-8. [PMID: 28920178 DOI: 10.1007/s00268-017-4232-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
366 Zhao Y, Hao Y, Ji H, Fang Y, Guo Y, Sha W, Zhou Y, Pang X, Southerland WM, Califano JA, Gu X. Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo. Cancer Prev Res (Phila) 2010;3:787-96. [PMID: 20501859 DOI: 10.1158/1940-6207.CAPR-09-0243] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
367 Hernandez-Vargas H, Lambert MP, Le Calvez-Kelm F, Gouysse G, McKay-Chopin S, Tavtigian SV, Scoazec JY, Herceg Z. Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. PLoS One. 2010;5:e9749. [PMID: 20305825 DOI: 10.1371/journal.pone.0009749] [Cited by in Crossref: 142] [Cited by in F6Publishing: 127] [Article Influence: 12.9] [Reference Citation Analysis]
368 Li W, Warner N, Sozzi V, Yuen L, Colledge D, Li T, Zhuang H, Locarnini S, Revill PA. Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype. Hepatol Int 2013;7:443-50. [PMID: 26201776 DOI: 10.1007/s12072-012-9411-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
369 Moinfar Z, Dambach H, Faustmann PM. Influence of drugs on gap junctions in glioma cell lines and primary astrocytes in vitro. Front Physiol 2014;5:186. [PMID: 24904426 DOI: 10.3389/fphys.2014.00186] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
370 Arizumi T, Ueshima K, Minami T, Kono M, Chishina H, Takita M, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Sakurai T, Nishida N, Kudo M. Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma. Liver Cancer. 2015;4:253-262. [PMID: 26734579 DOI: 10.1159/000367743] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 12.2] [Reference Citation Analysis]
371 Yan W, Wistuba II, Emmert-Buck MR, Erickson HS. Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites. Am J Cancer Res 2011;1:275-300. [PMID: 21938273 DOI: 10.1158/1538-7445.am2011-275] [Cited by in Crossref: 10] [Cited by in F6Publishing: 50] [Article Influence: 1.4] [Reference Citation Analysis]
372 Lee YC, Morgenstern H, Greenland S, Tashkin DP, Papp J, Sinsheimer J, Cao W, Hashibe M, You NC, Mao JT, Cozen W, Mack TM, Zhang ZF. A case-control study of the association of the polymorphisms and haplotypes of DNA ligase I with lung and upper-aerodigestive-tract cancers. Int J Cancer 2008;122:1630-8. [PMID: 18059021 DOI: 10.1002/ijc.23274] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
373 Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, Higashi H, Musashi M, Iwabuchi K, Suzuki M, Yamada G, Azuma T, Hatakeyama M. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA. 2008;105:1003-1008. [PMID: 18192401 DOI: 10.1073/pnas.0711183105] [Cited by in Crossref: 408] [Cited by in F6Publishing: 367] [Article Influence: 31.4] [Reference Citation Analysis]
374 Bouchard N, Laberge F, Raby B, Martin S, Lacasse Y. Adjuvant chemotherapy in resected lung cancer: two-year experience in a university hospital. Can Respir J 2008;15:270-4. [PMID: 18716690 DOI: 10.1155/2008/462147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
375 Katono K, Sato Y, Kobayashi M, Nagashio R, Ryuge S, Igawa S, Ichinoe M, Murakumo Y, Saegusa M, Masuda N. S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma. Onco Targets Ther 2017;10:5273-9. [PMID: 29138580 DOI: 10.2147/OTT.S145072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
376 Obaji N, Elom H, Agwu U, Nwigwe C, Ezeonu P, Umeora O. Awareness and Practice of Breast Self-Examination among Market Women in Abakaliki, South East Nigeria. Ann Med Health Sci Res 2013;3:7-12. [PMID: 23634322 DOI: 10.4103/2141-9248.109457] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
377 Figueroa-Protti L, Soto-Molinari R, Calderón-Osorno M, Mora J, Alpízar-Alpízar W. Gastric Cancer in the Era of Immune Checkpoint Blockade. J Oncol 2019;2019:1079710. [PMID: 31662748 DOI: 10.1155/2019/1079710] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
378 Andersen CL, Christensen LL, Thorsen K, Schepeler T, Sørensen FB, Verspaget HW, Simon R, Kruhøffer M, Aaltonen LA, Laurberg S, Ørntoft TF. Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. Br J Cancer 2009;100:511-23. [PMID: 19156145 DOI: 10.1038/sj.bjc.6604884] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 6.4] [Reference Citation Analysis]
379 Mu LN, Lu QY, Yu SZ, Jiang QW, Cao W, You NC, Setiawan VW, Zhou XF, Ding BG, Wang RH. Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer. 2005;116:972-983. [PMID: 15856451 DOI: 10.1002/ijc.21137] [Cited by in Crossref: 86] [Cited by in F6Publishing: 60] [Article Influence: 5.4] [Reference Citation Analysis]
380 Mahdavinia M, Bishehsari F, Ansari R, Norouzbeigi N, Khaleghinejad A, Hormazdi M, Rakhshani N, Malekzadeh R. Family history of colorectal cancer in Iran. BMC Cancer 2005;5:112. [PMID: 16143045 DOI: 10.1186/1471-2407-5-112] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
381 Song MA, Tiirikainen M, Kwee S, Okimoto G, Yu H, Wong LL. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma. PLoS One. 2013;8:e55761. [PMID: 23437062 DOI: 10.1371/journal.pone.0055761] [Cited by in Crossref: 75] [Cited by in F6Publishing: 68] [Article Influence: 9.4] [Reference Citation Analysis]
382 Cho W, Pradhan R, Chen HY, Weng YH, Chu HY, Tseng FG, Lin CP, Jiang JK. Rapid Staining of Circulating Tumor Cells in Three-Dimensional Microwell Dialysis (3D-μDialysis) Chip. Sci Rep 2017;7:11385. [PMID: 28900219 DOI: 10.1038/s41598-017-09829-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
383 Zhang M, Zhao QC, Liu YP, Yang L, Zhu HM, Chhetri JK. Prognostic analysis and comparison of colon cancer in Han and Hui patients. World J Gastroenterol 2014;20:5082-6. [PMID: 24803822 DOI: 10.3748/wjg.v20.i17.5082] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
384 Zhou X, Shi H, Jiang G, Zhou Y, Xu J. Antitumor activities of ginseng polysaccharide in C57BL/6 mice with Lewis lung carcinoma. Tumour Biol. 2014;35:12561-12566. [PMID: 25204674 DOI: 10.1007/s13277-014-2576-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
385 Li XP, Yang XY, Biskup E, Zhou J, Li HL, Wu YF, Chen ML, Xu F. Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma. Oncotarget 2015;6:22880-9. [PMID: 26078356 DOI: 10.18632/oncotarget.4412] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
386 Gong AM, Li XY, Xie YQ, Jia ZD, Li YX, Zou YY, Xu CQ, Wang ZY. Association between CD14 SNP -159 C/T and gastric cancer: an independent case-control study and an updated meta-analysis. Onco Targets Ther 2016;9:4337-42. [PMID: 27486336 DOI: 10.2147/OTT.S95807] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
387 Deng B, Zhu JM, Wang Y, Liu TT, Ding YB, Xiao WM, Lu GT, Bo P, Shen XZ. Intratumor hypoxia promotes immune tolerance by inducing regulatory T cells via TGF-β1 in gastric cancer. PLoS One 2013;8:e63777. [PMID: 23723999 DOI: 10.1371/journal.pone.0063777] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis]
388 Clifford RJ, Zhang J, Meerzaman DM, Lyu MS, Hu Y, Cultraro CM, Finney RP, Kelley JM, Efroni S, Greenblum SI. Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma. Hepatology. 2010;52:2034-2043. [PMID: 21105107 DOI: 10.1002/hep.23943] [Cited by in Crossref: 92] [Cited by in F6Publishing: 76] [Article Influence: 9.2] [Reference Citation Analysis]
389 Nozaki I, Nasu J, Kubo Y, Tanada M, Nishimura R, Kurita A. Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery. World J Surg. 2010;34:1548-1554. [PMID: 20217411 DOI: 10.1007/s00268-010-0518-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
390 Wang P, Zhang C, Yu P, Tang B, Liu T, Cui H, Xu J. Regulation of colon cancer cell migration and invasion by CLIC1-mediated RVD. Mol Cell Biochem. 2012;365:313-321. [PMID: 22426742 DOI: 10.1007/s11010-012-1271-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
391 Lichthardt S, Kerscher A, Dietz UA, Jurowich C, Kunzmann V, von Rahden BH, Germer CT, Wiegering A. Original article: role of adjuvant chemotherapy in a perioperative chemotherapy regimen for gastric cancer. BMC Cancer 2016;16:650. [PMID: 27538392 DOI: 10.1186/s12885-016-2708-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
392 Iwata T, Kondo Y, Kimura O, Morosawa T, Fujisaka Y, Umetsu T, Kogure T, Inoue J, Nakagome Y, Shimosegawa T. PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment. Sci Rep 2016;6:39296. [PMID: 27966626 DOI: 10.1038/srep39296] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 7.6] [Reference Citation Analysis]
393 Dong L, Yu L, Li H, Shi L, Luo Z, Zhao H, Liu Z, Yin G, Yan X, Lin Z. An NAD+-Dependent Deacetylase SIRT7 Promotes HCC Development Through Deacetylation of USP39. iScience 2020;23:101351. [PMID: 32711345 DOI: 10.1016/j.isci.2020.101351] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
394 Zhang C, Li C, Chen X, Zhou Y, Yin B, Ni R, Zhang Y, Liu J. Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma. Clin Transl Oncol 2017;19:1507-17. [PMID: 28589433 DOI: 10.1007/s12094-017-1697-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
395 Liang J, Lv X, Lu C, Ye X, Chen X, Fu J, Luo C, Zhao Y. Prognostic factors of patients with Gliomas - an analysis on 335 patients with Glioblastoma and other forms of Gliomas. BMC Cancer 2020;20:35. [PMID: 31941467 DOI: 10.1186/s12885-019-6511-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 28.0] [Reference Citation Analysis]
396 Toh CK, Heng D, Ong YK, Leong SS, Wee J, Tan EH. Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma. Br J Cancer 2005;92:1382-7. [PMID: 15812546 DOI: 10.1038/sj.bjc.6602525] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
397 Liu X, Xu T, Hu X, Chen X, Zeng K, Sun L, Wang S. Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer. Cancer Manag Res. 2018;10:857-865. [PMID: 29731665 DOI: 10.2147/cmar.s158016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
398 Lin TA, Lin JS, Wagner T, Pham N. Stereotactic body radiation therapy in primary hepatocellular carcinoma: current status and future directions. J Gastrointest Oncol 2018;9:858-70. [PMID: 30505586 DOI: 10.21037/jgo.2018.06.01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
399 Tang CT, Liang Q, Yang L, Lin XL, Wu S, Chen Y, Zhang XT, Gao YJ, Ge ZZ. RAB31 Targeted by MiR-30c-2-3p Regulates the GLI1 Signaling Pathway, Affecting Gastric Cancer Cell Proliferation and Apoptosis. Front Oncol 2018;8:554. [PMID: 30534536 DOI: 10.3389/fonc.2018.00554] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
400 Heavey S, Godwin P, Baird AM, Barr MP, Umezawa K, Cuffe S, Finn SP, O'Byrne KJ, Gately K. Strategic targeting of the PI3K-NFκB axis in cisplatin-resistant NSCLC. Cancer Biol Ther 2014;15:1367-77. [PMID: 25025901 DOI: 10.4161/cbt.29841] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
401 Zhu L, Li L, Li Y, Wang J, Wang Q. Chinese Herbal Medicine as an Adjunctive Therapy for Breast Cancer: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2016;2016:9469276. [PMID: 27239216 DOI: 10.1155/2016/9469276] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
402 Fang F, Yu L, Zhong Y, Yao L. TGFB1 509 C/T polymorphism and colorectal cancer risk: a meta-analysis. Med Oncol 2010;27:1324-8. [PMID: 20012233 DOI: 10.1007/s12032-009-9383-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
403 Jardon-Xicotencatl S, Díaz-Torres R, Marroquín-Cardona A, Villarreal-Barajas T, Méndez-Albores A. Detoxification of Aflatoxin-Contaminated Maize by Neutral Electrolyzed Oxidizing Water. Toxins (Basel) 2015;7:4294-314. [PMID: 26512692 DOI: 10.3390/toxins7104294] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
404 Zhu HT, Hasan AM, Liu RB, Zhang ZC, Zhang X, Wang J, Wang HY, Wang F, Shao JY. Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma. Oncotarget. 2016;7:45637-45648. [PMID: 27317768 DOI: 10.18632/oncotarget.10082] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
405 Lu W, Dai B, Ma W, Zhang Y. A novel taspine analog, HMQ1611, inhibits growth of non-small cell lung cancer by inhibiting angiogenesis. Oncol Lett 2012;4:1109-13. [PMID: 23162661 DOI: 10.3892/ol.2012.855] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
406 Chen L, Li M, Li H. Milk and yogurt intake and breast cancer risk: A meta-analysis. Medicine (Baltimore) 2019;98:e14900. [PMID: 30896640 DOI: 10.1097/MD.0000000000014900] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 4.5] [Reference Citation Analysis]
407 Zeng GQ, Zhang PF, Deng X, Yu FL, Li C, Xu Y, Yi H, Li MY, Hu R, Zuo JH. Identification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics. Mol Cell Proteomics. 2012;11:M111.013946. [PMID: 22298307 DOI: 10.1074/mcp.m111.013946] [Cited by in Crossref: 45] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
408 Moghimi-Dehkordi B, Safaee A, Zali MR. Comparison of colorectal and gastric cancer: survival and prognostic factors. Saudi J Gastroenterol 2009;15:18-23. [PMID: 19568550 DOI: 10.4103/1319-3767.43284] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
409 Walsh T, Macey R, Kerr AR, Lingen MW, Ogden GR, Warnakulasuriya S. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev 2021;7:CD010276. [PMID: 34282854 DOI: 10.1002/14651858.CD010276.pub3] [Reference Citation Analysis]
410 Yang L, Kuang LG, Zheng HC, Li JY, Wu DY, Zhang SM, Xin Y. PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma. World J Gastroenterol. 2003;9:35-39. [PMID: 12508347 DOI: 10.3748/wjg.v9.i1.35] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
411 Awuah PK, Rhieu BH, Singh S, Misse A, Monga SP. β-Catenin loss in hepatocytes promotes hepatocellular cancer after diethylnitrosamine and phenobarbital administration to mice. PLoS One. 2012;7:e39771. [PMID: 22761897 DOI: 10.1371/journal.pone.0039771] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
412 Shah MH, Telang SD, Shah PM, Patel PS. Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis. Glycoconj J 2008;25:279-90. [PMID: 18158621 DOI: 10.1007/s10719-007-9086-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
413 Reynolds P, Hurley SE, Gunier RB, Yerabati S, Quach T, Hertz A. Residential proximity to agricultural pesticide use and incidence of breast cancer in California, 1988-1997. Environ Health Perspect 2005;113:993-1000. [PMID: 16079069 DOI: 10.1289/ehp.7765] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
414 Buijs M, Reyes DK, Pawlik TM, Blackford AL, Salem R, Messersmith WA, Weekes CD, Mulcahy M, Kamel IR, Geschwind JF. Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. Cancer. 2013;119:1042-1049. [PMID: 23132335 DOI: 10.1002/cncr.27859] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
415 Gauthier A, Ho M. Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update. Hepatol Res. 2013;43:147-154. [PMID: 23145926 DOI: 10.1111/j.1872-034x.2012.01113.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 71] [Article Influence: 12.6] [Reference Citation Analysis]
416 Di Maio M, Gridelli C, Gallo C, Manzione L, Brancaccio L, Barbera S, Robbiati SF, Ianniello GP, Ferraù F, Piazza E, Frontini L, Rosetti F, Carrozza F, Bearz A, Spatafora M, Adamo V, Isa L, Iaffaioli RV, Di Salvo E, Perrone F. Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer. Br J Cancer 2004;90:2288-96. [PMID: 15162156 DOI: 10.1038/sj.bjc.6601810] [Cited by in Crossref: 86] [Cited by in F6Publishing: 68] [Article Influence: 5.1] [Reference Citation Analysis]
417 Li X, Wang X, Li Z, Zhang Z, Zhang Y. Chemokine receptor 7 targets the vascular endothelial growth factor via the AKT/ERK pathway to regulate angiogenesis in colon cancer. Cancer Med. 2019;8:5327-5340. [PMID: 31348616 DOI: 10.1002/cam4.2426] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
418 Feng CP, Ding HX, Liu YX, Di QF, Liu Y, Liang J, Liu GX. Water-Soluble Total Flavonoids Isolated from Isodon lophanthoides var. gerardianus (Benth.) H. Hara Promote Hepatocellular Carcinoma Sensitivity to 5-Fluorouracil. Evid Based Complement Alternat Med 2021;2021:6623212. [PMID: 34335833 DOI: 10.1155/2021/6623212] [Reference Citation Analysis]
419 Zhang X, Chang A. Molecular predictors of EGFR-TKI sensitivity in advanced non-small cell lung cancer. Int J Med Sci 2008;5:209-17. [PMID: 18645621 DOI: 10.7150/ijms.5.209] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
420 Guo L, Xu D, Lu Y, Peng J, Jiang L. Detection of circulating tumor cells by reverse transcription‑quantitative polymerase chain reaction and magnetic activated cell sorting in the peripheral blood of patients with hepatocellular carcinoma. Mol Med Rep 2017;16:5894-900. [PMID: 28849093 DOI: 10.3892/mmr.2017.7372] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
421 Villanueva C, Romieu G, Salvat J, Chaigneau L, Merrouche Y, N'guyen T, Vuillemin AT, Demarchi M, Dobi E, Pivot X. Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer-Study BES 06. Target Oncol 2013;8:137-43. [PMID: 23609057 DOI: 10.1007/s11523-013-0279-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
422 Arbuthnot P, Thompson LJ. Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma. World J Gastroenterol 2008;14:1670-81. [PMID: 18350598 DOI: 10.3748/wjg.14.1670] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
423 Salvo G, Ramirez PT, Leitao M, Cibula D, Fotopoulou C, Kucukmetin A, Rendon G, Perrotta M, Ribeiro R, Vieira M, Baiocchi G, Falconer H, Persson J, Wu X, Căpilna ME, Ioanid N, Mosgaard BJ, Berlev I, Kaidarova D, Olawaiye AB, Liu K, Nobre SP, Kocian R, Saso S, Rundle S, Noll F, Tsunoda AT, Palsdottir K, Li X, Ulrikh E, Hu Z, Pareja R. International radical trachelectomy assessment: IRTA study. Int J Gynecol Cancer 2019;29:635-8. [PMID: 30765489 DOI: 10.1136/ijgc-2019-000273] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 9.5] [Reference Citation Analysis]
424 Worthley DL, Giraud AS, Wang TC. Stromal fibroblasts in digestive cancer. Cancer Microenviron. 2010;3:117-125. [PMID: 21209778 DOI: 10.1007/s12307-009-0033-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
425 Doi T, Boku N, Kato K, Komatsu Y, Yamaguchi K, Muro K, Hamamoto Y, Sato A, Koizumi W, Mizunuma N, Takiuchi H. Phase I/II study of capecitabine plus oxaliplatin (XELOX) plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer. Jpn J Clin Oncol 2010;40:913-20. [PMID: 20462981 DOI: 10.1093/jjco/hyq069] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
426 Figueiroa MS, César Vieira JS, Leite DS, Filho RC, Ferreira F, Gouveia PS, Udrisar DP, Wanderley MI. Green tea polyphenols inhibit testosterone production in rat Leydig cells. Asian J Androl. 2009;11:362-370. [PMID: 19330017 DOI: 10.1038/aja.2009.2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
427 Yang YX, Sun XF, Cheng AL, Zhang GY, Yi H, Sun Y, Hu HD, Hu P, Ye F, Chen ZC. Increased expression of HSP27 linked to vincristine resistance in human gastric cancer cell line. J Cancer Res Clin Oncol. 2009;135:181-189. [PMID: 18758817 DOI: 10.1007/s00432-008-0460-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
428 Zhuo Y, Guo Q. [Down-regulated βIII-tubulin expression can reverse paclitaxel resistance in A549/taxol cells lines]. Zhongguo Fei Ai Za Zhi 2014;17:581-7. [PMID: 25130963 DOI: 10.3779/j.issn.1009-3419.2014.08.01] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
429 Sun ZG, Wang Z, Liu XY, Liu FY. Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy. World J Surg 2011;35:70-7. [PMID: 21046381 DOI: 10.1007/s00268-010-0829-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
430 Mu LN, Cao W, Zhang ZF, Cai L, Jiang QW, You NC, Goldstein BY, Wei GR, Chen CW, Lu QY. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. Cancer Causes Control. 2007;18:665-675. [PMID: 17503006 DOI: 10.1007/s10552-007-9012-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
431 Businello G, Parente P, Mastracci L, Pennelli G, Traverso G, Milione M, Bellan E, Michelotto M, Kotsafti A, Grillo F, Fassan M. The Pathologic and Molecular Landscape of Esophageal Squamous Cell Carcinogenesis. Cancers (Basel) 2020;12:E2160. [PMID: 32759723 DOI: 10.3390/cancers12082160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
432 Rouquier S, Pillaire MJ, Cazaux C, Giorgi D. Expression of the microtubule-associated protein MAP9/ASAP and its partners AURKA and PLK1 in colorectal and breast cancers. Dis Markers 2014;2014:798170. [PMID: 24876664 DOI: 10.1155/2014/798170] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
433 Zhao HY, Chen GY, Huang Y, Li XL, Feng JF, Shi MQ, Cheng Y, Ma LX, Zhang YP, Gu CP, Song XQ, Zhou D, Zhang L. Erlotinib plus capecitabine as first-line treatment for older Chinese patients with advanced adenocarcinoma of the lung (C-TONG0807): an open-label, single arm, multicenter phase II study. Medicine (Baltimore) 2015;94:e249. [PMID: 25590835 DOI: 10.1097/MD.0000000000000249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
434 Shida D, Fang X, Kordula T, Takabe K, Lépine S, Alvarez SE, Milstien S, Spiegel S. Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. Cancer Res. 2008;68:6569-6577. [PMID: 18701480 DOI: 10.1158/0008-5472.can-08-0411] [Cited by in Crossref: 100] [Cited by in F6Publishing: 53] [Article Influence: 7.7] [Reference Citation Analysis]
435 Lu X, Liu DP, Xu Y. The gain of function of p53 cancer mutant in promoting mammary tumorigenesis. Oncogene 2013;32:2900-6. [PMID: 22824795 DOI: 10.1038/onc.2012.299] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
436 Song JH, Son SH, Kay CS, Jang HS. Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy. Oncotarget. 2015;6:33952-33960. [PMID: 26376679 DOI: 10.18632/oncotarget.5581] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
437 Xiong Y, Xie CR, Zhang S, Chen J, Yin ZY. Detection of a novel panel of somatic mutations in plasma cell-free DNA and its diagnostic value in hepatocellular carcinoma. Cancer Manag Res 2019;11:5745-56. [PMID: 31303788 DOI: 10.2147/CMAR.S197455] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
438 Kim MY, Cho WD, Hong KP, Choi da B, Hong JW, Kim S, Moon YR, Son SM, Lee OJ, Lee HC, Song HG. Novel monoclonal antibody against beta 1 integrin enhances cisplatin efficacy in human lung adenocarcinoma cells. J Biomed Res 2016;30:217-24. [PMID: 27533932 DOI: 10.7555/JBR.30.2016K0005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
439 Zhang J, Zhang M, Ma H, Song X, He L, Ye X, Li X. A meta-analysis of the prognostic significance of Golgi protein 73 in hepatocellular carcinoma in Chinese patients. Arch Med Sci 2020;16:1104-10. [PMID: 32863999 DOI: 10.5114/aoms.2019.83821] [Reference Citation Analysis]
440 Gauthier A, Ho M. Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update. Hepatol Res. 2013;43:147-154. [PMID: 23145926 DOI: 10.1111/j.1872-034x.2012.01113] [Reference Citation Analysis]
441 Genç R, Çağlı S, Yüce İ, Vural A, Okuducu H, Patıroğlu T, Güney E. The role of H. pylori in the development of laryngeal squamous cell carcinoma. Dis Markers 2013;35:447-9. [PMID: 24198443 DOI: 10.1155/2013/950701] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
442 Barone C, Basso M, Schinzari G, Pozzo C, Trigila N, D’Argento E, Quirino M, Astone A, Cassano A. Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer. Gastric Cancer. 2007;10:104-111. [PMID: 17577620 DOI: 10.1007/s10120-007-0415-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
443 Kikuchi J, Takashina T, Kinoshita I, Kikuchi E, Shimizu Y, Sakakibara-Konishi J, Oizumi S, Marquez VE, Nishimura M, Dosaka-Akita H. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Lung Cancer. 2012;78:138-143. [PMID: 22925699 DOI: 10.1016/j.lungcan.2012.08.003] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 8.7] [Reference Citation Analysis]
444 Xue X, Asuquo I, Hong L, Gao J, Dong Z, Pang L, Jiang T, Meng M, Fan J, Wen J, Deng H, Zang X, Ma X, Guo R, Qin C, Meng Y, Ma H, Han J, Wang H, Xue Z, Zhao D, Lin D, Pan L. Catalog of Lung Cancer Gene Mutations Among Chinese Patients. Front Oncol 2020;10:1251. [PMID: 32850378 DOI: 10.3389/fonc.2020.01251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
445 Dong Y, Shi Q, Nakagawa-Goto K, Wu PC, Bastow KF, Morris-Natschke SL, Lee KH. Antitumor agents 269. Non-aromatic ring-A neotanshinlactone analog, TNO, as a new class of potent antitumor agents. Bioorg Med Chem Lett 2009;19:6289-92. [PMID: 19819136 DOI: 10.1016/j.bmcl.2009.09.092] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
446 Holgersson G, Sandelin M, Hoye E, Bergström S, Henriksson R, Ekman S, Nyman J, Helsing M, Friesland S, Holgersson M, Lundström KL, Janson C, Birath E, Mörth C, Blystad T, Ewers SB, Löden B, Bergqvist M. Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer. Med Oncol 2012;29:3176-82. [PMID: 22565809 DOI: 10.1007/s12032-012-0247-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
447 Zhang H, Wei S, Ning S, Jie Y, Ru Y, Gu Y. Evaluation of TGFβ, XPO4, elF5A2 and ANGPTL4 as biomarkers in HCC. Exp Ther Med 2013;5:119-27. [PMID: 23251252 DOI: 10.3892/etm.2012.750] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
448 Schoffelen R, van der Graaf WT, Sharkey RM, Franssen GM, McBride WJ, Chang CH, Laverman P, Goldenberg DM, Oyen WJ, Boerman OC. Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method. EJNMMI Res 2012;2:5. [PMID: 22284761 DOI: 10.1186/2191-219X-2-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
449 Islam M, Datta J, Lang JC, Teknos TN. Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma. Oral Oncol 2014;50:448-56. [PMID: 24565984 DOI: 10.1016/j.oraloncology.2014.01.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
450 Cui JF, Liu YK, Zhou HJ, Kang XN, Huang C, He YF, Tang ZY, Uemura T. Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis. World J Gastroenterol. 2008;14:1257-1262. [PMID: 18300354 DOI: 10.3748/wjg.14.1257] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
451 Yamaguchi T, Fushida S, Yamamoto Y, Tsukada T, Kinoshita J, Oyama K, Miyashita T, Tajima H, Ninomiya I, Munesue S, Harashima A, Harada S, Yamamoto H, Ohta T. Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination. Gastric Cancer. 2016;19:1052-1065. [PMID: 26621525 DOI: 10.1007/s10120-015-0579-8] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 14.5] [Reference Citation Analysis]
452 Alphs HH, Gambhira R, Karanam B, Roberts JN, Jagu S, Schiller JT, Zeng W, Jackson DC, Roden RB. Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2. Proc Natl Acad Sci U S A 2008;105:5850-5. [PMID: 18413606 DOI: 10.1073/pnas.0800868105] [Cited by in Crossref: 115] [Cited by in F6Publishing: 104] [Article Influence: 8.8] [Reference Citation Analysis]
453 Ali N, Allam H, May R, Sureban SM, Bronze MS, Bader T, Umar S, Anant S, Houchen CW. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts. J Virol. 2011;85:12292-12303. [PMID: 21937640 DOI: 10.1128/jvi.05920-11] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
454 Rao S, Starling N, Cunningham D, Benson M, Wotherspoon A, Lüpfert C, Kurek R, Oates J, Baselga J, Hill A. Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer. Br J Cancer. 2008;99:868-874. [PMID: 19238629 DOI: 10.1038/sj.bjc.6604622] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
455 Siddique A, Kowdley KV. Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma. Clin Liver Dis 2011;15:281-96, vii-x. [PMID: 21689613 DOI: 10.1016/j.cld.2011.03.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
456 FitzGerald LM, Patterson B, Thomson R, Polanowski A, Quinn S, Brohede J, Thornton T, Challis D, Mackey DA, Dwyer T, Foote S, Hannan GN, Stankovich J, McKay JD, Dickinson JL. Identification of a prostate cancer susceptibility gene on chromosome 5p13q12 associated with risk of both familial and sporadic disease. Eur J Hum Genet 2009;17:368-77. [PMID: 18830231 DOI: 10.1038/ejhg.2008.171] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
457 Jeong YK, Oh JY, Yoo JK, Lim SH, Kim EH. The Biofunctional Effects of Mesima as a Radiosensitizer for Hepatocellular Carcinoma. Int J Mol Sci 2020;21:E871. [PMID: 32013255 DOI: 10.3390/ijms21030871] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
458 Messick TE, Smith GR, Soldan SS, McDonnell ME, Deakyne JS, Malecka KA, Tolvinski L, van den Heuvel APJ, Gu BW, Cassel JA, Tran DH, Wassermann BR, Zhang Y, Velvadapu V, Zartler ER, Busson P, Reitz AB, Lieberman PM. Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth. Sci Transl Med 2019;11:eaau5612. [PMID: 30842315 DOI: 10.1126/scitranslmed.aau5612] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 33.0] [Reference Citation Analysis]
459 Sewell J, Ranasinghe W, De Silva D, Ayres B, Ranasinghe T, Hounsome L, Verne J, Persad R. Trends in penile cancer: a comparative study between Australia, England and Wales, and the US. Springerplus 2015;4:420. [PMID: 26301167 DOI: 10.1186/s40064-015-1191-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
460 Harper K, Armelagos G. The changing disease-scape in the third epidemiological transition. Int J Environ Res Public Health 2010;7:675-97. [PMID: 20616997 DOI: 10.3390/ijerph7020675] [Cited by in Crossref: 98] [Cited by in F6Publishing: 43] [Article Influence: 8.9] [Reference Citation Analysis]
461 Caravati-Jouvenceaux A, Launoy G, Klein D, Henry-Amar M, Abeilard E, Danzon A, Pozet A, Velten M, Mercier M. Health-related quality of life among long-term survivors of colorectal cancer: a population-based study. Oncologist 2011;16:1626-36. [PMID: 21987427 DOI: 10.1634/theoncologist.2011-0036] [Cited by in Crossref: 59] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
462 Hassanain M, Al-Alem F, Simoneau E, Traiki TA, Alsaif F, Alsharabi A, Al-Faris H, Al-Saleh K. Colorectal cancer liver metastasis trends in the kingdom of Saudi Arabia. Saudi J Gastroenterol 2016;22:370-4. [PMID: 27748323 DOI: 10.4103/1319-3767.191142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
463 Li M, Jin Y, Sun WJ, Yu Y, Bai J, Tong DD, Qi JP, Du JR, Geng JS, Huang Q. Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma. J Pathol. 2009;219:87-95. [PMID: 19479822 DOI: 10.1002/path.2571] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
464 Kwon HC, Oh SY, Lee S, Kim SH, Kim HJ. Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: a pilot study. World J Gastroenterol. 2007;13:6231-6235. [PMID: 18069765 DOI: 10.3748/wjg.13.6231] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
465 Cheng J, Han W, Wang Z, Shao Y, Wang Y, Zhang Y, Li Z, Xu X, Zhang Y. Hepatocellular Carcinoma Growth Is Inhibited by Euphorbia helioscopia L. Extract in Nude Mice Xenografts. Biomed Res Int 2015;2015:601015. [PMID: 26090427 DOI: 10.1155/2015/601015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
466 Jiwa M, Long A, Shaw T, Pagey G, Halkett G, Pillai V, Meng X. The management of acute adverse effects of breast cancer treatment in general practice: a video-vignette study. J Med Internet Res 2014;16:e204. [PMID: 25274131 DOI: 10.2196/jmir.3585] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
467 Fuentes-González AM, Contreras-Paredes A, Manzo-Merino J, Lizano M. The modulation of apoptosis by oncogenic viruses. Virol J 2013;10:182. [PMID: 23741982 DOI: 10.1186/1743-422X-10-182] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
468 Tong MJ, Sun HE, Hsien C, Lu DS. Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic. Dig Dis Sci. 2010;55:826-835. [PMID: 19960258 DOI: 10.1007/s10620-009-1059-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
469 Pietras RJ, Weinberg OK. Antiangiogenic Steroids in Human Cancer Therapy. Evid Based Complement Alternat Med 2005;2:49-57. [PMID: 15841278 DOI: 10.1093/ecam/neh066] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
470 Chai J, Shen X, Feng R, Cheng J, Chen Y, Zha Z, Jia S, Liang H, Zhao T, Sha R, Shi Y, Li K, Wang D. eCROPS-CA: a systematic approach toward effective and sustainable cancer prevention in rural China. BMC Cancer 2015;15:233. [PMID: 25886568 DOI: 10.1186/s12885-015-1253-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
471 de Jong GM, Hendriks T, Eek A, Oyen WJ, Heskamp S, Bleichrodt RP, Boerman OC. Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin. Ann Surg Oncol 2009;16:2065-73. [PMID: 19430843 DOI: 10.1245/s10434-009-0477-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
472 Shamsdin SA, Karimi MH, Hosseini SV, Geramizadeh B, Fattahi MR, Mehrabani D, Moravej A. Associations of ICOS and PD.1 Gene Variants with Colon Cancer Risk in The Iranian Population. Asian Pac J Cancer Prev 2018;19:693-8. [PMID: 29580042 DOI: 10.22034/APJCP.2018.19.3.693] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
473 Zhou X, Wen Y, Tian Y, He M, Ke X, Huang Z, He Y, Liu L, Scharf A, Lu M, Zhang G, Deng Y, Yan Y, Mayer MP, Chen X, Zou F. Heat Shock Protein 90α-Dependent B-Cell-2-Associated Transcription Factor 1 Promotes Hepatocellular Carcinoma Proliferation by Regulating MYC Proto-Oncogene c-MYC mRNA Stability. Hepatology 2019;69:1564-81. [PMID: 30015413 DOI: 10.1002/hep.30172] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
474 Yang Z, Zhang J, Lu Y, Xu Q, Tang B, Wang Q, Zhang W, Chen S, Lu L, Chen X. Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization. Oncotarget. 2015;6:43090-43098. [PMID: 26506519 DOI: 10.18632/oncotarget.5719] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
475 Montella M, D'Arena G, Crispo A, Capunzo M, Nocerino F, Grimaldi M, Barbieri A, D'Ursi AM, Tecce MF, Amore A, Galdiero M, Ciliberto G, Giudice A. Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Int J Endocrinol 2015;2015:854530. [PMID: 26491442 DOI: 10.1155/2015/854530] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
476 Jin YJ, Chung YH, Kim JA, Park W, Lee D, Shim JH, Lee D, Kim KM, Lim YS, Lee HC. Predisposing factors of hepatocellular carcinoma recurrence following complete remission in response to transarterial chemoembolization. Dig Dis Sci. 2013;58:1758-1765. [PMID: 23361574 DOI: 10.1007/s10620-013-2562-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
477 Corrêa GT, Bandeira GA, Cavalcanti BG, Santos FB, Rodrigues Neto JF, Guimarães AL, Haikal DS, De Paula AM. Analysis of ECOG performance status in head and neck squamous cell carcinoma patients: association with sociodemographical and clinical factors, and overall survival. Support Care Cancer 2012;20:2679-85. [PMID: 22314971 DOI: 10.1007/s00520-012-1386-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
478 Zhu AX, Sahani DV, Duda DG, di Tomaso E, Ancukiewicz M, Catalano OA, Sindhwani V, Blaszkowsky LS, Yoon SS, Lahdenranta J, Bhargava P, Meyerhardt J, Clark JW, Kwak EL, Hezel AF, Miksad R, Abrams TA, Enzinger PC, Fuchs CS, Ryan DP, Jain RK. Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J Clin Oncol. 2009;27:3027-3035. [PMID: 19470923 DOI: 10.1200/jco.2008.20.9908] [Cited by in Crossref: 353] [Cited by in F6Publishing: 168] [Article Influence: 29.4] [Reference Citation Analysis]
479 Chen Z, Saad R, Jia P, Peng D, Zhu S, Washington MK, Zhao Z, Xu Z, El-Rifai W. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma. Cancer. 2013;119:1985-1993. [PMID: 23456798 DOI: 10.1002/cncr.28002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
480 Lu L, Wu M, Zhao F, Fu W, Li W, Li X, Liu T. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis. Oncotarget. 2016;7:69087-69096. [PMID: 27634907 DOI: 10.18632/oncotarget.12011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
481 Fujita T, Yanagihara K, Takeshita F, Aoyagi K, Nishimura T, Takigahira M, Chiwaki F, Fukagawa T, Katai H, Ochiya T, Sakamoto H, Konno H, Yoshida T, Sasaki H. Intraperitoneal delivery of a small interfering RNA targeting NEDD1 prolongs the survival of scirrhous gastric cancer model mice. Cancer Sci 2013;104:214-22. [PMID: 23106787 DOI: 10.1111/cas.12054] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
482 Watanabe Y, Kim HS, Castoro RJ, Chung W, Estecio MR, Kondo K, Guo Y, Ahmed SS, Toyota M, Itoh F, Suk KT, Cho MY, Shen L, Jelinek J, Issa JP. Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology. 2009;136:2149-2158. [PMID: 19375421 DOI: 10.1053/j.gastro.2009.02.085] [Cited by in Crossref: 87] [Cited by in F6Publishing: 68] [Article Influence: 7.3] [Reference Citation Analysis]
483 Wu X, Yang T, Liu X, Guo JN, Xie T, Ding Y, Lin M, Yang H. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer. Tumour Biol 2016;37:5493-501. [PMID: 26566627 DOI: 10.1007/s13277-015-4372-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
484 Park PG, Jo SJ, Kim MJ, Kim HJ, Lee JH, Park CK, Kim H, Lee KY, Kim H, Park JH, Dong SM, Lee JM. Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis. Oncotarget 2017;8:80325-35. [PMID: 29113306 DOI: 10.18632/oncotarget.18170] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
485 Al-Abdullah ES. Synthesis and anticancer activity of some novel tetralin-6-yl-pyrazoline, 2-thioxopyrimidine, 2-oxopyridine, 2-thioxo-pyridine and 2-iminopyridine derivatives. Molecules 2011;16:3410-9. [PMID: 21512449 DOI: 10.3390/molecules16043410] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
486 Cheng C, Wang R, Li Y, Pan Y, Zhang Y, Li H, Zheng D, Zheng S, Shen X, Sun Y, Chen H. EGFR Exon 18 Mutations in East Asian Patients with Lung Adenocarcinomas: A Comprehensive Investigation of Prevalence, Clinicopathologic Characteristics and Prognosis. Sci Rep 2015;5:13959. [PMID: 26354324 DOI: 10.1038/srep13959] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
487 Karam SM, Tomasetto C, Rio MC. Amplification and invasiveness of epithelial progenitors during gastric carcinogenesis in trefoil factor 1 knockout mice. Cell Prolif 2008;41:923-35. [PMID: 19040570 DOI: 10.1111/j.1365-2184.2008.00562.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
488 Lu W, Ke H, Qianshan D, Zhen W, Guoan X, Honggang Y. Apatinib has anti-tumor effects and induces autophagy in colon cancer cells. Iran J Basic Med Sci 2017;20:990-5. [PMID: 29085592 DOI: 10.22038/IJBMS.2017.9263] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
489 Fu DJ, Wang L, Chouairi FK, Rose IM, Abetov DA, Miller AD, Yamulla RJ, Schimenti JC, Flesken-Nikitin A, Nikitin AY. Gastric squamous-columnar junction contains a large pool of cancer-prone immature osteopontin responsive Lgr5-CD44+ cells. Nat Commun 2020;11:84. [PMID: 31901081 DOI: 10.1038/s41467-019-13847-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
490 Wang Z, Jiang L, Huang C, Li Z, Chen L, Gou L, Chen P, Tong A, Tang M, Gao F, Shen J, Zhang Y, Bai J, Zhou M, Miao D, Chen Q. Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma. Mol Cell Proteomics 2008;7:1639-50. [PMID: 18458027 DOI: 10.1074/mcp.M700520-MCP200] [Cited by in Crossref: 65] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
491 Li Q, Liu X, Jin K, Lu M, Zhang C, Du X, Xing B. NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity. BMC Cancer 2017;17:605. [PMID: 28859621 DOI: 10.1186/s12885-017-3570-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
492 An SW, Kim NK, Chung HC. Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening. Yonsei Med J 2009;50:331-4. [PMID: 19568592 DOI: 10.3349/ymj.2009.50.3.331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
493 Wei Y, Lv J, Guo Y, Bian Z, Gao M, Du H, Yang L, Chen Y, Zhang X, Wang T, Chen J, Chen Z, Yu C, Huo D, Li L; China Kadoorie Biobank Collaborative Group. Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose-response meta-analysis. Eur J Epidemiol 2020;35:567-78. [PMID: 31754945 DOI: 10.1007/s10654-019-00585-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
494 Hsu FT, Liu YC, Liu TT, Hwang JJ. Curcumin Sensitizes Hepatocellular Carcinoma Cells to Radiation via Suppression of Radiation-Induced NF-κB Activity. Biomed Res Int 2015;2015:363671. [PMID: 26539482 DOI: 10.1155/2015/363671] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
495 Isobe T, Aoyagi K, Koufuji K, Shirouzu K, Kawahara A, Taira T, Kage M. Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer. Int J Clin Oncol. 2013;18:293-304. [PMID: 22350022 DOI: 10.1007/s10147-012-0378-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
496 Liang D, Liang S, Jin J, Li D, Shi J, He Y. Gastric cancer burden of last 40 years in North China (Hebei Province): A population-based study. Medicine (Baltimore) 2017;96:e5887. [PMID: 28079831 DOI: 10.1097/MD.0000000000005887] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
497 Romick-Rosendale LE, Lui VWY, Grandis JR, Wells SI. The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma. Mutat Res 2013;743-744:78-88. [PMID: 23333482 DOI: 10.1016/j.mrfmmm.2013.01.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
498 Schoenleber SJ, Kurtz DM, Talwalkar JA, Roberts LR, Gores GJ. Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis. Br J Cancer. 2009;100:1385-1392. [PMID: 19401698 DOI: 10.1038/sj.bjc.6605017] [Cited by in Crossref: 148] [Cited by in F6Publishing: 125] [Article Influence: 12.3] [Reference Citation Analysis]
499 Datta J, Smith A, Lang JC, Islam M, Dutt D, Teknos TN, Pan Q. microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ. Oncogene 2012;31:4045-53. [PMID: 22158047 DOI: 10.1038/onc.2011.565] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 5.6] [Reference Citation Analysis]
500 Osime OC, Momoh MI, Irowa OO, Obumse A. Gastric carcinoma--a big challenge in a poor economy. J Gastrointest Cancer. 2010;41:101-106. [PMID: 20052563 DOI: 10.1007/s12029-009-9118-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
501 Yang S, Jiang L, Zhang MZ. 11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal Tumorigenesis. J Oncobiomarkers 2013;1:002. [PMID: 23936870 DOI: 10.13188/2325-2340.1000002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
502 Lee SH, Choi WJ, Sung SW, Kim YK, Kim CH, Zo JI, Park KJ. Endoscopic cryotherapy of lung and bronchial tumors: a systematic review. Korean J Intern Med 2011;26:137-44. [PMID: 21716589 DOI: 10.3904/kjim.2011.26.2.137] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
503 Olugbami JO, Damoiseaux R, France B, Onibiyo EM, Gbadegesin MA, Sharma S, Gimzewski JK, Odunola OA. A comparative assessment of antiproliferative properties of resveratrol and ethanol leaf extract of Anogeissus leiocarpus (DC) Guill and Perr against HepG2 hepatocarcinoma cells. BMC Complement Altern Med 2017;17:381. [PMID: 28768515 DOI: 10.1186/s12906-017-1873-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
504 Chen MJ, Wu DC, Lin JM, Wu MT, Sung FC. Etiologic factors of gastric cardiac adenocarcinoma among men in Taiwan. World J Gastroenterol. 2009;15:5472-5480. [PMID: 19916179 DOI: 10.3748/wjg.15.5472] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
505 Park SK, Jung YK, Chung DH, Kim KK, Park YH, Lee JN, Kwon OS, Kim YS, Choi DJ, Kim JH. Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience. Korean J Intern Med. 2013;28:428-438. [PMID: 23864801 DOI: 10.3904/kjim.2013.28.4.428] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
506 Ludovini V, Flacco A, Bianconi F, Ragusa M, Vannucci J, Bellezza G, Chiari R, Minotti V, Pistola L, Tofanetti FR, Siggillino A, Baldelli E, Sidoni A, Daddi N, Puma F, Varella-Garcia M, Crinò L. Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients. Cancer Chemother Pharmacol 2013;71:671-80. [PMID: 23314677 DOI: 10.1007/s00280-012-2056-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
507 Sakamoto J, Matsui T, Kodera Y. Paclitaxel chemotherapy for the treatment of gastric cancer. Gastric Cancer. 2009;12:69-78. [PMID: 19562460 DOI: 10.1007/s10120-009-0505-z] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 5.9] [Reference Citation Analysis]
508 Suwa K, Yamaguchi T, Yoshida K, Murata M, Ichimura M, Tsuneyama K, Seki T, Okazaki K. Smad Phospho-Isoforms for Hepatocellular Carcinoma Risk Assessment in Patients with Nonalcoholic Steatohepatitis. Cancers (Basel) 2020;12:E286. [PMID: 31991602 DOI: 10.3390/cancers12020286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
509 Li SH, Wang Z, Liu XY. Metastasis-associated protein 1 (MTA1) overexpression is closely associated with shorter disease-free interval after complete resection of histologically node-negative esophageal cancer. World J Surg. 2009;33:1876-1881. [PMID: 19575142 DOI: 10.1007/s00268-009-0119-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
510 Sonnweber B, Dlaska M, Skvortsov S, Dirnhofer S, Schmid T, Hilbe W. High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC). J Clin Pathol 2006;59:255-9. [PMID: 16505275 DOI: 10.1136/jcp.2005.027615] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]